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Abstract
Understanding the drivers of growth in health care expenditure is crucial for forecasting future health care
requirements and to ameliorate inefficient expenditure. This paper considers the detailed breakdown of
hospital inpatient expenditures across the period 2007/08 to 2014/15. Decomposition techniques are
used to unpick the observed rise in expenditure into a component due to a change in the distribution of
characteristics, for example, greater prevalence of morbidity, and a component due to structural changes
in the impact of such characteristics on expenditures (coefficient effects, for example, due to technological
change). This is undertaken at the mean using standard decomposition techniques, but also across
the full distribution of expenditures to gain an understanding of where in the distribution growth and
its determinants are most relevant. Decomposition at the mean indicates a larger role for a structural
change in characteristics rather than a change in coefficients. A key driver is an increased prevalence of
comorbidities. When considering the full distribution we observe a decrease in expenditure at the bottom
of the distribution (bottom two quintiles) but increasing expenditure thereafter. The largest increases are
observed at the top of the expenditure distribution. Where changes in structural characteristics dominate
changes in coefficients in explaining the rise in expenditure. Increases in comorbidities (and the average
number of first diagnoses) across the two periods, together with increases in non-elective long stay
episodes and non-elective bed days are important drivers of expenditure increases.
JEL codes: H51; J11; I19.
Keywords: English National Health Service, Health care expenditure growth, Decomposition analysis,
Drivers of expenditure.
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1. Introduction and Background
The continued rise in Health Care Expenditure (HCE) relative to national income has attracted a great
deal of attention and raises important questions about the sustainability of health services provision and
their ability to meet population needs. Since 1978-79 while UK public spending on health rose by an
average of 3.8% per year in real terms, the average growth of the economy was 2.2% a year (Licchetta
and Stelmach 2016). In 2012 this equated to approximately 7.9% of GDP. The year-on-year rise in HCE
is considered one of the greatest challenges to long-term fiscal sustainability (Licchetta and Stelmach
2016). Understanding the drivers of the demand for health care is critical in informing the level and
distribution of future health care spending. Of particular relevance are changing demographics in an
ageing population, increases in chronic conditions and comorbidities, and rising public expectations of
the benefits of health care. Supply side factors including increasing relative health care costs, and the
impact of technological change also heavily influence expenditure decisions. Exploring how these factors
have changed over time and their relative contribution to expenditure growth is key to understanding the
rise in health care expenditure and for forecasting future expenditure requirements.
This paper considers changes in hospital inpatient expenditure (a key component of HCE) over time and
how these relate to changes in the determinants of such expenditure using individual-level administrative
data. Using decomposition techniques in the spirit of Dormont et al. (2006) allows us to attribute changes
in expenditure to a component due to structural changes, for example in demand drivers such as an
ageing population, or changing morbidity characteristics and a component due to a change in the
relationship between such characteristics and expenditure. The latter might arise due to changing
input prices or technological progress. We further consider how these relationships and the attribution
of expenditure to structural and technological change varies across the full distribution of inpatient
expenditure. This allows us to look beyond mean expenditure growth to consider whether growth is driven
disproportionately by expenditure at certain points across it’s distribution (see de Meijer et al. (2013) for
an application to the Netherlands). This is important in understanding the relative impact of structural
and technological change at different parts of the distribution of expenditure. It allows the exploration of
questions such as: has technological change played a relatively greater role in constraining costs at the
bottom rather than the top of the expenditure distribution?
We use administrative data from Hospital Episode Statistics (HES) recorded at an individual patient
level and covering all inpatient activity in England across the two financial periods 2007/08 and 2014/15.
We have approximately 66,000 observations in 2007/08 and 75,000 in 2014/15, corresponding to a
1% sample of patients in each year. By matching admissions to their associated costs we are able
to establish the change in hospital inpatient expenditure over the seven year period to 2014/15. HES
includes demographic information, diagnoses and treatments, which allows us to explore how changes
over time are determined by changes in the distribution of these characteristics (structural changes)
together with changes in the expenditure response to these characteristics.
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2. Heath care services in the UK
Health care delivery in the UK is predominantly provided by the publicly funded NHS.1 Approximately
80% of health care is financed through public funds, the remainder being privately financed with this split
between public and private expenditure remaining fairly constant over time. This paper focuses exclusively
on NHS expenditure and provision of inpatient hospital services. The UK NHS is comprised of four
separately funded systems for each of England, Northern Ireland, Scotland, and Wales with block grants
used to determine the level of public funding to each of the devolved administrations. Each administration
is free to decide on the level of expenditure to devote to health care and the broad functional split between
primary care often termed Family Health Services and secondary care, often referred to as Hospital
and Community Health Services: HCHS. The latter accounted for approximately 61% and 64% of total
(NHS) health care expenditure in 2007/08 and 2014/15 respectively (Office for National Statistics 2017).
HCHS covers all hospital treatments both for admitted patient care (patients who stay for at least one
night as inpatients and day cases discharged on the same day as they are admitted) and outpatient
care. Family Health Services largely covers the provision of general medical practice or ambulatory care
which accounts for approximately 17% of expenditure. Prescribing by general medical practitioners and
non-NHS provision represent smaller shares of around 12% and 8% respectively (Office for National
Statistics 2017). Financing for the NHS is derived from conventional income and expenditure taxes, with
a minority (approximately 2%) sought from patient contributions limited to a small number of services (for
example, dental care, prescription charges, and eye tests).2 With an effectively zero copayment the NHS
has relied on the gate-keeping role of primary care physicians, and waiting and queuing for treatment
also playing a role in regulating demand for secondary care services.
Recent reforms, mostly in England, commencing in the financial year 2003/04 have seen the adoption
of fixed prices for hospital treatments, greater discretion over the use of funds by NHS hospitals and
empowerment of patients through encouraging choice and ‘shopping around’. These changes have been
evidenced to increase hospital activity (Charlesworth et al. 2014).
2.1. Basic trends in Health Care Expenditure
Health care expenditure as a proportion of GDP has more than doubled over the past 50 years from
approximately 4% in 1970 to 9% in 2012 (OECD 2017). This is illustrated in Figure 1.3 Notable rises
coincide with recessions (and a corresponding decrease in GDP) and the period in the 1990s under a
government policy of year-on-year real terms increases in funding for the NHS. In the more recent past
NHS expenditure as a proportion of GDP rose steeply in the two years to the end of 2009 to coincide
with the great recession and then decreased during the recent period where health funding has been
maintained in real terms while GDP began to rise (see Aragón et al. (2016) for details).
Focusing on the last decade, which included a large and sustained increase in health expenditures as a
percentage of GDP, real NHS expenditure per capita increased over 30% for all four countries of the UK
(HM Treasury 2010-2017), see Figure 2.
1 A exception is the provision of dental care which increasingly is provided privately.
2 Patient charges from NHS prescribed medicines in England are currently (from 01.April.2017) £8.60 per item dispensed. Charges
for dental treatments vary across jurisdictions with England paying between £20.60 and £244.30 depending on the service provided.
See: https://www.gov.uk/government/speeches/nhs-prescription-charges-from-april-2017, accessed 21.August.2017
3 There is a break in the data in 2013, for details see OECD (2017).
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Figure 1: Total Expenditure on Health as Percentage of GDP
Figure 2: Health Care Expenditure per capita in the UK
Given the substantial role of hospital services in the provision of health care in England, together with the
availability of inpatient hospital administrative records over a number of years which can be costed in a
reasonably consistent manner, we focus our attention on this particular aspect of the NHS. This allows us
to investigate changes in expenditure over the recent period between 2007/08 to 2014/15 and potential
explanations for the observed changes. These are broken down between changes in expenditure due to
changes in the structural distribution of patient characteristics (for example, an ageing society, changing
morbidity patterns) and changes in the expenditure consequences of such characteristics (for example,
due to technological change or changes in input prices).
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3. Decomposition of health care expenditures
Using data for a sample of people with public health insurance, Dormont et al. (2006) use decomposition
techniques to understand the sources of change in HCE between 1992 and 2000 in France. They
consider expenditure on hospital care, physician consultations and prescriptions for ten-year age groups,
and include both individuals with zero expenditure and patients with positive expenditure. Applying
microsimulation techniques they calculate for each type of expenditure and age group, the probability
of participation (i.e. having positive expenditure) and the average predicted expenditure for those with
positive health care utilisation. These estimates are then used to calculate the change in expenditure
between the two years, separating the effect of changes in health care provision for a given morbidity from
changes in the incidence of morbidity. Their results indicate that for hospital care changes in the provision
of care have contributed to increasing expenditure, while changes in morbidity have slightly reduced
expenditure for people over 40 years of age. Other changes, however, also account for a significant part
of the overall observed change in expenditures. Using the results from the microsimulation exercise
they estimate the effects at the aggregate level, finding that for hospital care changes in morbidity have
reduced expenditure, however they are partially offset by the effect of the changes in the provision of
care. Changes in patients’ age explain only a small proportion of the change in hospital expenditure.
More recently, de Meijer et al. (2013) analyse the change in the distribution of HCE between 1998
and 2004 in the Netherlands (during this period, in 2001, hospitals’ budgets where relaxed to address
increasing waiting lists) using a combination of insurance claims, hospital discharges and mortality
data. They divide overall HCE into two components: hospital care and pharmaceuticals, and analyse
whether changes in hospital activity are reflected in pharmaceutical expenditure. They decompose
the change in the distribution of HCE using the methodology proposed by Chernozhukov et al. (2012),
which decomposes the change into changes in its structural determinants (e.g. population age) and
changes in the impact the determinants have on HCE (for example, brought about via technology
improvements). Importantly the method allows this decomposition to take place across the full distribution
of HCEs such that a comparison of the determinants can be made at different points in the distribution.
More standard approaches to decomposition analysis (e.g. Oaxaca (1973) and Blinder (1973)) focus
exclusively on decomposing changes in outcomes solely at the mean. The results of de Meijer et al.
(2013) indicate that changes in HCE determinants and changes in their impact differ at the bottom of the
expenditure distribution compared to the top. For individuals with positive expenditure, both determinants
(characteristics) and their impact contribute to increase expenditure throughout the distribution. However,
their relative importance varies. At the bottom of the expenditure distribution both factors contribute
equally, while at the top, the contribution of the change in the impact is around one and a half times the
contribution of the change in determinants. For hospital care, the growth in expenditure over the period is
mostly explained by changes in structural determinants.
As part of calculating HCE projections, the OECD estimated expenditure growth for member states over
the period 1970-2002 (OECD 2006). For the UK, they found that public health expenditure grew on
average 3.8% per year, of which it was estimated that 0.1% was due to demographic effects and 2.1% to
income effects (assuming health care is a normal good and an income elasticity of health expenditure
equal to 1). The remaining 1.5% was ascribed to a residual effect, attributed to changes in medical
technology and changes in relative prices. As improvements in medical technology can reduce cost
and accordingly the relative price of health services, then depending on the elasticity of demand for
health care, this may lead to increases or decreases in the demand for these services and associated
expenditure.
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4. Methods
4.1. Oaxaca-Blinder Decomposition
Oaxaca (1973) and Blinder (1973) analysed the wages of different groups (male/women, white/black) in
the US, to investigate the role of discrimination in the observed differentials. Both authors, separately,
developed methods to decompose the average wage differential into a part explained by observed worker
characteristics (job tenure, ability, etc.) and a part due to discrimination. The latter can be thought of
as the differential impact of a given characteristic, say ability, on wages observed between men and
women. In the absence of discrimination, both men and women would be expected to be paid equally
for a given level of ability, with all else held equal. Accordingly, the approach aims at decomposing
wages into a discriminatory effect, arising from differential pay between two groups with the same
characteristics, and a composition effect, where differences in wages arise from legitimate differences in
the groups. Applying the Oaxaca-Blinder methodology, we decompose the difference in average hospital
expenditures observed between two financial years, and consider its determinants due to structural
changes in characteristics of patients and care provision, and changes in the expenditure response to
those characteristics. The former can be thought of as picking up changes in demographic and morbidity
characteristics, and the latter due to technological changes or changes in input prices. We assume
individual hospital expenditures, Yit in a given financial year can be estimated as:
Yit = X
′
itβt + it (1)
where Xit includes patient (age, sex) and hospital admission (number, length, diagnoses recorded)
characteristics and a constant. β is a vector of parameters and it is an idiosyncratic error. In our model,
t denotes the time period under investigation - either 2007/08 or 2014/15. Note that these two years
represent repeated cross-sections of health care inpatient users rather than a panel of a fixed set of
individuals observed over time.
The difference between the average individual hospital costs in two different financial years can be
calculated using Equation (1) evaluated on the mean for each period, assuming it has mean zero ∀t.
Assuming two periods denoted t = 0 and t = 1, and supressing the individual subscript for ease of
notation, the equation can be rearranged to show the components of the difference as follows:4
E(Y1)− E(Y0) = E(X ′1β1 + 1)− E(X ′0β0 + 0)
= E(X1)
′β1 − E(X0)′β0
= {E(X1)− E(X0)}′β0︸ ︷︷ ︸
A
+E(X0)
′(β1 − β0)︸ ︷︷ ︸
B
+ {E(X1)− E(X0)}′(β1 − β0)︸ ︷︷ ︸
C
(2)
Equation (2) illustrates the decomposition of the difference in the mean outcome between the two periods
(t = 0 and t = 1). The component labelled A shows the contribution due to a change in characteristics
of patients (X0 and X1) across the two periods assuming the relationship between characteristics and
expenditure are observed at time t = 0 (herein referred to as the “characteristics effect”). The component
4 We follow the rearrangement proposed by Jann (2008).
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labelled B is the contribution to the change in outcomes due to a change in relationship between
characteristic X0 and the outcome across the two periods, captured by the difference in coefficients
(β1 − β0). That is, (β1 − β0) indicates how, for example, a change in the efficiency of treating patients
with characteristics X0 informs the change in mean expenditures across the two time periods. The final
component, C, is the effect of an interaction term between A and B. The focus of our interest lies in the
relative contributions of components A and B in explaining the change in expenditures across the two
periods.
The decomposition is straightforward for cardinal variables. However, for categorical variables that require
a set of dummy variables to be defined together with a reference category, Oaxaca and Ransom (1999)
show that the standard decomposition is dependent on the chosen reference category. Accordingly, the
decomposition into effects of characteristics and coefficients is not invariant to the reference category.
This is clearly problematic for empirical analyses where dummy variables are often specified. The
problem arises due to a lack of agreement on which category should form the reference group. Yun
(2005) proposes a simple solution to this problem based on the idea that the characteristics and
coefficients effects for each outcome of the categorical variable can be computed as the average effect
for that outcome when the effects are calculated by alternating the reference group. That is, multiple
regressions and decompositions can be estimated, each specifying a different reference group and by
taking averages of appropriate terms across the regressions the characteristic and coefficient effects for
each category can be identified. Since changing the reference category for dummy variables impacts on
the constant term, the above approach will also lead to a modified estimate of the constant. In practice
the characteristics and coefficient effects can be derived from a single regression without the need to
estimate multiple specifications each with a different reference category. If we think of Xit in equation (1)
as a discrete variable with three categories (k = 1, . . . , 3), then the model can be extended to:
Yit = αt + β¯t +
3∑
k=1
Xkit
(
βkt − β¯kt
)
+ it (3)
where β¯kt = (β1t + β2t + β3t) /3 and β1t = 0, and we explicitly note the constant αt. Equation (3) is the
normalised regression where the estimate is simply the average of three sets of estimates where the
reference group is varied (see Yun (2005) for further discussion). The overall constant term is given by
αt + β¯it. Decomposition analyses follows directly on the specification in model (3).
The approach generalises to the situation with multiple categorical variables. Due to the approach
averaging across specifications where the reference category is changed, this leads to effects that are
equal in magnitude, but with opposing directions for a single dummy variable containing two categories.
We perform the analysis using the Oaxaca-Blinder decomposition developed for Stata by Jann (2008) in
Stata 14 (StataCorp. 2015). For categorical variables, for example sex, we use the normalize() option
which will report the decomposition results for all categories.
In section 6.1 we decompose the natural logarithm of expenditures across the two years of data, such
that (2) can be represented as E(lnY1) − E(lnY2). Accordingly decomposition is undertaken on a
logarithmic scale, but results are retransformed (exponentiated) to the original scale prior to reporting.
Retransforming the data allows for a more intuitive interpretation of the decomposition effects. Since this
involves a ratio of expenditures across the period it informs of the percentage increase (or decrease) in
expenditure due to a change in coefficients or change in structural characteristics.
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4.2. Counterfactual Decomposition
The Oaxaca-Blinder decomposition described in Section 4.1 focuses on decomposing the average
differences between groups. The key decompositional effects are differences between observed and
counterfactual distributions evaluated at the mean. The counterfactual can be thought of as the result
either of a change in the distribution of a set of characteristics predictive of the outcome, or a change in
the relationship between the characteristics and the outcome. Essentially the counterfactual represents
the ‘what if’ scenarios - for example, component A in Equation (2) reflects the impact of a change
in the distribution of characteristics, X, evaluated using the estimated relationship with the outcome
(β0) observed in the first of the two time periods, that is at t = 0. The counterfatual to the observed
relationship at time t = 0 (which estimates the relationship between X0 and Y0 as β0) is the impact
of characteristics observed in period t = 1, that is, X1 applied to the relationship with Y0 observed in
period t = 0, that is, β0. Accordingly, X1β0 represents the counterfactual ‘what if’ scenario at t = 1 for
the estimated relationship X0β0 observed at time t = 0. That is, by applying the relationship between
outcomes and characteristics at time t = 0 what would the outcome be if the set of characteristics were
those observed at time t = 1. Whereas the Oaxaxa-Blinder approach evaluates the counterfactual at the
mean of the outcome, other techniques consider the difference between groups across the full distribution
of outcomes. Fortin et al. (2011) provide an overview of methods to decompose the difference between
two groups (or two time periods) into different explanatory factors.
To investigate the change in HCE across its full distribution (rather than solely at the mean) and to
decompose this into changes in characteristics and changes in the impact of characteristics we follow
the distributional regression approach developed by Chernozhukov et al. (2013). They propose a
methodology to undertake counterfactual analysis, that is, to evaluate the effect of changes in the
(marginal) distribution of an outcome variable Y given a set of covariates X, either via a change in the
distribution of X or a change in the relationship between X and Y (the conditional distribution of Y given
X (FY |X)). In general for a given outcome, Y , and set of characteristics, X, we are interested in the
effect on the marginal distribution of the outcome (FY ) for a change in: (i) the marginal distribution of the
characteristics (FX) holding fixed the conditional distribution of the outcome (FY |X); (ii) the conditional
distribution of the outcome (FY |X) holding the marginal distribution of characteristics (FX) fixed. To
address these effects requires the estimation of counterfactual distributions.
Chernozhukov et al. (2013) propose a decomposition method based on distributional regression (for
example, see Foresi and Peracchi (1995)). More formally, we can define the marginal distribution of
characteristics in time period j (j = 0, 1) as FX(j)(x), and the conditional distribution of the outcome
given characteristics X as FY(j)(y|x). The insight behind the decomposition comes from the fact that
the marginal distribution of the outcome, FY(j) , is equivalent to it’s conditional distribution integrated over
the distribution of covariates. We can represent this as: FY(j)(y) =
∫
FY(j)(y|x)dFX(j)(x). Counterfactual
analysis follows directly by generalising the above, such that, for example, FY(j|k)(y) represents the
marginal distribution of the outcome in preriod j based on the distribution of characteristics measured
in period k (k = 0, 1). Accordingly, we have: FY(j|k)(y) =
∫
FY(j)(y|x)dFX(k)(x). For example, the
hypothetical distribution of HCE in period t = 0 if the relationship between characteristics and outcomes
remained as observed in time period t = 0, but applied to the distribution of characteristics observed in
period t = 1 is given by: FY(0|1)(y) =
∫
FY(0)(y|x)dFX(1)(x). The approach allows comparison between
marginal and counterfactual distributions of outcomes and their decomposition. To simplify notation, we
drop the parentheses such that FY(0|0) is the observed distribution of expenditures in period t = 0 and
FY(0|1) is the counterfactual distribution of expenditures assuming patients had characteristics observed
in period t = 1; and similarly for FY(1|1) and FY(1|0) . In each (financial) year, we observe hospital costs Yt
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and patient and hospital characteristics Xt. The observed distributions of hospital costs are FY(0|0) and
FY(1|1) , and their difference can be decomposed into differences due to differences in the coefficients (1)
and to differences in characteristics (2) as:
FY(1|1) − FY(0|0) =
[
FY(1|1) − FY(0|1)
]︸ ︷︷ ︸
(1)
+
[
FY(0|1) − FY(0|0)
]︸ ︷︷ ︸
(2)
(4)
Implementation of the approach requires estimation of the conditional distribution of outcomes and of
the marginal distribution of characteristics. It is assumed that the conditional distributions, FY(j|k) , are
well defined where there is common support across the distribution of characteristics, X0 and X1. In our
application this assumes that the support of patient characteristics in the initial year includes that of the
final year, χ1 ⊆ χ0. This appears a reasonable assumption.
We perform the analysis using the decomposition commands developed for Stata by Chernozhukov et al.
(2013) in Stata 14 (StataCorp. 2015).
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5. Data
We focus on the population of inpatient hospital users, that is, people who attended hospital at least
once, in either of the two financial years 2007/08 and 2014/15. There are two main sources of data: the
Admitted Patient Care part of the Hospital Episode Statistics (APC-HES) (NHS Digital 2015; The Health
and Social Care Information Centre 2009) and the NHS Reference Costs (RC) (Department of Health
2015; Department of Health 2009). APC-HES records hospital activity as episodes, periods under the
care of one consultant. The information recorded for each episode includes: start and end dates, age and
sex of the patient, type of admission and diagnoses. We can identify the Healthcare Resource Group(s)
(HRG, NHS equivalent to DRGs) associated with each episode using the episode information from
APC-HES and the HRG RC Grouper for the corresponding financial year (National Casemix Office 2015;
The Casemix Service 2008), which also provides the number of excess bed days (days above a trimpoint
defined to improve comparability of episodes by separating unusually long episodes). All episodes have a
core HRG, which corresponds to the primary reason for admission or treatment, and they may also have
unbundled HRG(s), which account for activity with significant costs (e.g. Chemotherapy, Radiotherapy,
Specialist Palliative Care, High Cost Drugs). This separation (previously each episode had only one
HRG) was introduced so HRGs represent activity and costs more accurately (National Casemix Office
2015).
The cost associated with each HRG is available in the RC, which report a (weighted) national average of
the cost of each HRG based on the costs reported by NHS providers (Department of Health 2014). Each
HRG can have more than one cost, depending on the settings (inpatient, day cases, non-elective) in
which it has activity.
Using RCs rather than the National Tariff (NT, see Monitor and NHS England (2013)) allows us to
compare years further apart. The version of the HRG classification used for RC and NT has changed
over time, with RC adopting a new version a few years earlier; RC started using HRG4 in 2006/075
(Department of Health 2008) and NT in 2009/10 (DH PbR Team 2009). This greater span is required to
ensure sufficient time has elapsed between periods under comparison to allow for meaningful change to
occur.
To calculate the cost of each episode we use both the core and the unbundled HRGs. The core HRG is
matched with its cost in the relevant setting, i.e. we use the elective cost for elective inpatient admissions,
the day case cost for day cases, and the non-elective cost (short- or long stay, depending on the length of
the episode) for the rest of the episodes; the cost for excess bed days, if these are present, is also based
on the core HRG. And the unbundled HRG(s) (if any) are matched with their overall national average
(without distinguishing between elective and non-elective).
Our dependant variable is the total cost per patient in 2007/08 and 2014/15, so we calculate its total per
patient in each financial year, using the RC for that year. We consider only episodes with a positive cost.
Accordingly, our data set considers a cross-section of inpatient hospital users in 2007/08 and a further
cross-section of hospital users in 2014/15. Some individuals may be present in both data sets should
they have had an inpatient episode in both financial years.
The variation in costs we observe is a combination of changes in the costs of hospital activity and
changes in that activity. To take into account the effect of inflation and make the costs comparable, we
5 We did not use 2006/07 as it was not possible to use the RC Grouper for that year.
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use the Department of Health’s Pay & Price Series (Department of Health 2016) to deflate the costs in
2014/15 (i.e. express them in £ of 2007/08). Therefore, the change we observe is not driven by costs’
inflation, but likely to reflect changes in hospital activity, such as technological change and complexity of
cases.
As explanatory variables we consider patient characteristics, clinical information and activity levels in
each financial year. In terms of patients characteristics, we consider the age at the beginning of the
financial year and the sex of the patient. Using the (ICD-10) diagnoses recorded in each episode we
create two sets of indicators based on the diagnosis groups defined in the International Shortlist for
Hospital Morbidity Tabulation (ISHMT) (World Health Organization n.d.).6 The first set of indicators
considers only the first diagnosis; the second set considers the following four diagnoses. Accordingly, the
first set of indicators measure the different reasons a patient is admitted to hospital (multiple admissions
with the same primary diagnosis will have only one indicator equal to one) while the second set of
indicators measures comorbidities the patient had during the financial year,7 we use this second set of
indicators to calculate the total number of comorbidities. In terms of activity we calculate totals for the
number of episodes (total, elective/non-elective, short(day cases)/long) and number of days admitted
to hospital (total and elective/non-elective). To account for provider effects we need to associate each
patient to one provider, since it is possible for patients to be admitted in different providers throughout the
year, we use the one where the patient had most episodes.
There are approximately 6.6 million hospital patients in the financial year 2007/08 and 7.5 million in
2014/15. To speed up computational time we take a random 1% sample from each year. Accordingly, the
sample for analysis consist of 66,079 in 2007/08 and 75,343 in 2014/15.
5.1. Descriptive Statistics of the Sample
Table 1 shows the descriptive statistics of our sample: 1% of the patients in each financial year, after
excluding those who have more than 365 days admitted to hospital in the year.8 The average cost per
patient increased from £2,965.27 in 2007/08 to £3,606.87 in 2014/15; an increase of 21.6%. Patients
were, on average, slightly older while the proportion of males remained constant (and less than the
proportion of females) across the two periods. There were more diagnoses recorded in 2014/15 both in
the average number of first diagnoses and the number of comorbidities recorded.9 Patients had more
episodes in total in 2014/15 compared to 2007/08. While the number of elective episodes remains
constant over the period, its composition changes - daycases increase and inpatients decrease. For
both short and long stay non-electives, the average number of episodes increased. Elective hospital
stays have become shorter while non-elective stays were longer in 2014/15 compared to 2007/08. The
6 ISHMT has 130 diagnosis groups listed under 20 chapters; the results on the main part use the 20 chapters (see Appendix A for
their description) and results using all 130 diagnosis group can be found in Appendix B
7 We focus on the first five diagnoses to avoid any potential issues arising from changes in the recording of diagnoses between the
two years we consider. The recording of diagnoses in HES changed between the two financial years we consider, in 2007/08 is
was possible to record up to 14 diagnoses and by 2014/15 this number had increased to 20. Additionally, in 2011 the HSCIC (now
NHS Digital) issued a list of diagnoses that are always considered to be clinically relevant and therefore should always be recorded
(Health and Social Care Information Centre 2017).
8 HES records finished episodes, therefore they are recorded on the financial year they end. Patients with long hospital stays can
appear to have more than 365 days in hospital in a financial year, there were 2,949 such observations in the data before extracting
the 1% sample.
9 The average number of first diagnoses is above one due to some patients having multiple admissions during the year with different
first diagnosis.
The determinants of health care expenditure growth 13
proportion of patients in the different types of providers remains fairly constant across the period except
for a shift towards teaching providers10 and Other Providers.11
The total number of patients increases between 2007/08 and 2014/15 by around 12% (in our sample the
increase is of 14%), while the population in England increased by less than 6% over the same period
(Office for National Statistics 2015; Office for National Statistics 2013). Accordingly, the proportion of
people admitted to hospital increased over the period. In terms of capacity, the total number of available
beds (overnight and day-only) increased by 2% (NHS England n.d.[b]; NHS England n.d.[a]).
10 In 2008/09 (the closest year to 2007/08 for which we have data) there were 25 teaching hospitals in England compared to 29 in
2013/14.
11 Other Providers consist largely of non-acute trusts. In 2007/08 these included mental health (MH) trusts and primary care
organisations (PCOs). In 2014/15, these included MH Trusts and community trusts together with a merger in October 2014 between
Ealing Hospital NHS Trust and The North West London Hospitals NHS Trust, which created one of the largest integrated acute and
community care trusts in the country.
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Table 1: Descriptive Statistics
2007/08 2014/15
Mean StdDev Mean StdDev
Cost (in £ of 2007/08) 2,965.27 5,277.25 3,606.87 6,506.78
Demographics
Age 49.97 25.35 51.64 25.41
Male 0.4661 0.4989 0.4655 0.4988
Morbidity
Number of different 1st diagnoses
based in 20 ISHMT chapters 1.26 0.61 1.33 0.70
based in 130 ISHMT groups 1.33 0.74 1.41 0.85
Number of Comorbidities (based on 130 ISHMT groups) 1.20 1.60 1.88 1.96
Activity
Total Episodes 2.03 4.49 2.17 2.84
Elective Episodes 1.09 4.17 1.09 2.26
Daycases 0.68 1.64 0.81 1.82
Inpatient 0.41 3.76 0.29 1.24
Non-Elective Episodes 0.93 1.56 1.08 1.83
Short Stay 0.18 0.49 0.22 0.53
Long Stay 0.75 1.46 0.86 1.73
Bed Days 5.01 13.91 5.10 15.72
Elective 0.95 4.69 0.84 6.71
Non-Elective 4.07 12.82 4.27 13.93
Provider Type
Large Provider 0.3612 0.4803 0.3153 0.4646
Medium Provider 0.2780 0.4480 0.2573 0.4371
Small Provider 0.1100 0.3129 0.0996 0.2995
Specialist Provider 0.0281 0.1651 0.0278 0.1645
Teaching Provider 0.2207 0.4147 0.2802 0.4491
Other Provider 0.0020 0.0441 0.0198 0.1393
Number of Observations 66,079 75,343
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6. Results
6.1. Decomposition at the mean of expenditures
Table 2 shows the results of the Oaxaca decomposition of the change in expenditure between 2007/08
and 2014/15. These are provided for model specifications that differ in the number of characteristics
used as control variables. The list of characteristics used for each model is shown in the bottom panel
of the table. The dependant variable in all regressions is the logarithm of expenditure per patient in
the relevant financial year. However, the results have been transformed to the original scale, so the
(geometric) mean12 of the cost in each year is expressed in pounds (deflated to 2007/08) and the
estimated difference (and its decomposition) is expressed as a ratio. For example, the geometric mean of
expenditure in 2007/08 is £1,561.10 and £1,673.97 in 2014/15.13 This represents a growth in expenditure
(on the log scale) of 7.23% across the period. This difference is decomposed into an effect due to a
change in characteristics (labelled Characteristics) and an effect due to a change in the relationship
between characteristics and expenditure (labelled Coefficients). In model specification (1) the increase in
costs due to changes in patients and hospital admission characteristics is 2.1$ (characteristics ratio =
1.0209). The change due to how characteristics relate to expenditure is 5.2% (coefficient ratio = 1.0524).
The interaction between characteristics and coefficients (how the characteristics relate to expenditure)
explains a further 0.2% of expenditure.
All estimates reported in the top panel of Table 2 are significant at 1%. Exceptions to this are specification
(7) for the effect of a change in coefficients and specifications (4) and (5) for the interaction term, which
have p-values > 0.10. In the first two specifications, the overall change is driven by the change in
coefficients. Once first diagnosis is included (specification (3) onwards) changes in characteristics
become the main component of the overall change in expenditure. The inclusion of comorbidities
(specification (4) onwards) changes not only the relative sizes of the effect of characteristics and
coefficients, but also the sign of the effect of coefficients.
We focus in detail on the results for the most basic and most complex specifications (1) and (7). Model
(1) considers only patient demographic characteristics (age and sex) as explanatory variables. Table
3 shows the full results for this specification. The first two columns present regression results for each
of the two financial years. Decomposition results are reported in the final three columns. The first row
reproduces the decomposition results reported in Table 2 (including significance levels and standard
errors). The second row shows the same decomposition but excluding the constant term, which is only
present in the results for the Coefficients. The regression results for the two financial years (first two
columns in Table 3) are broadly similar. In both years women, on average, attract lower cost and costs
generally increase with age, particularly from age 30-40 upwards.
The decomposition results explain the change in expenditures evaluated at the mean. Of the observed
7.2% increase in expenditure across the two periods, 2% can be explained by a change in characteristics
(demographic variables) and 5.2% by a change in the relationship between demographic variables and
expenditure. Note that this last effect includes a constant term; if this term is excluded, the effect of
the changes in characteristics becomes smaller and changes sign (-1%). This specification, given it’s
12 This is not the same as reported in the descriptives statistics in Table 1.
13 The geometric mean indicates the central tendency by calculating the nth root of the product of n numbers. This differs from
the arithmetic mean which calculates the average of a sum of n numbers. Another way of expressing the geometric mean is the
exponential of the arithmetic mean of the logarithm of the n numbers. Unless all numbers are equivalent, in which case the two
means coincide, the geometric mean is always less than the arithmetic mean.
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Table 2: Blinder-Oaxaca Decomposition of Hospital Costs Difference between 2007/08 and 2014/15
(1) (2) (3) (4) (5) (6) (7)
Cost in 2014/15 1,673.97 1,673.97 1,673.97 1,673.97 1,673.97 1,673.97 1,673.97
Cost in 2007/08 1,561.10 1,561.10 1,561.10 1,561.10 1,561.10 1,561.10 1,561.10
Difference 1.0723 1.0723 1.0723 1.0723 1.0723 1.0723 1.0723
Characteristics 1.0209 1.0232 1.0426 1.1149 1.1141 1.1027 1.0889
Coefficients 1.0524 1.0336 1.0228 0.9647 0.9602 0.9632 0.9933
Interaction 0.9981 1.0139 1.0056 0.9970 1.0024 1.0096 0.9913
Variables:
Demographics
Age X X X X X X X
Sex X X X X X X X
Activity
Total Episodes X X X X
Elective Episodes X
Daycases X
Inpatient X
Non-Elective Episodes X
Short Stay X
Long Stay X
Bed Days X X X X
Elective X X
Non-Elective X X
Morbidity
First Diagnosis X X X X X
Number of Comorbidities X X X X
Provider
Provider Type X X X
Number of Observations 2007/08 66,079
Number of Observations 2014/15 75,343
simplicity, is likely to mask other relevant characteristics related both to changes in expenditure and to
age.
A detailed breakdown of the decomposition results by individual covariates and groups of covariates is
also provided. For categorical variables, these are estimated using the normalize() option and report
results for all categories of a particular categorical variable, together with the overall effect of the variable
(between dashed lines). For example, in the case of sex, there are separate coefficients for males and
females. As the results are shown as a ratio, a ratio equal to one indicates no relationship with the
change in costs for that particular change in characteristic (or change in coefficient). The results show
that sex is not significantly related to the observed change in cost. Neither the distribution of males and
females, nor the relationship between sex and expenditure contribute to explaining the observed change
in expenditures across the period. That is, the ratio both for the effect of a change in characteristic and a
change in coefficient are close to unity.
Age, on the other hand, is significant for the change attributed to characteristics, coefficients and
the interaction term. The change in expenditure attributed to a change in characteristics is positively
correlated (ratios greater than one) for age groups from [10, 20) to [80, 120). This indicates that the rise
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Table 3: Blinder-Oaxaca Decomposition of Hospital Costs Difference between 2007/08 and 2014/15
- Specification (1)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
Decomposition (as ratio) 1.0209*** 1.0524*** 0.9981***
(0.0017) (0.0060) (0.0007)
Decomposition (as ratio) excluding Constant 1.0209 0.9882 0.9981
Male Reference Category 1.0000 0.9971 1.0000
(0.0001) (0.0026) (0.0000)
Female -0.0675*** -0.0553*** 1.0000 1.0033 1.0000
(0.0079) (0.0083) (0.0001) (0.0031) (0.0000)
Sex - total effect 1.0000 1.0004 1.0000
(0.0002) (0.0004) (0.0000)
Age Groups
[0, 5) Reference Category 0.9999 1.0008 1.0000
(0.0003) (0.0014) (0.0000)
[5, 10) -0.0317 -0.0262 1.0000 1.0005 1.0000
(0.0290) (0.0304) (0.0002) (0.0008) (0.0000)
[10, 20) 0.0641*** 0.1482*** 1.0020*** 1.0061*** 0.9990***
(0.0219) (0.0242) (0.0003) (0.0014) (0.0003)
[20, 30) -0.0207 -0.0096 1.0017*** 1.0021 0.9999
(0.0201) (0.0215) (0.0004) (0.0017) (0.0001)
[30, 40) 0.0481** 0.0401* 1.0035*** 1.0005 0.9999
(0.0196) (0.0214) (0.0004) (0.0018) (0.0003)
[40, 50) 0.1701*** 0.1301*** 1.0004** 0.9967* 1.0001
(0.0191) (0.0202) (0.0001) (0.0019) (0.0001)
[50, 60) 0.3244*** 0.1816*** 1.0006*** 0.9839*** 0.9990***
(0.0190) (0.0197) (0.0002) (0.0019) (0.0003)
[60, 70) 0.4704*** 0.3765*** 1.0027*** 0.9884*** 0.9990***
(0.0185) (0.0192) (0.0004) (0.0021) (0.0002)
[70, 80) 0.6129*** 0.5816*** 1.0020*** 0.9973 0.9999
(0.0185) (0.0194) (0.0007) (0.0021) (0.0001)
[80, 120) 0.8789*** 0.9694*** 1.0080*** 1.0125*** 1.0013***
(0.0191) (0.0197) (0.0011) (0.0019) (0.0003)
Age - total effect 1.0209*** 0.9885*** 0.9981***
(0.0017) (0.0031) (0.0007)
Constant 7.0603*** 7.1288*** - 1.0642*** -
(0.0157) (0.0165) (0.0069)
Adjusted R-squared 0.0811 0.0740
N 66,079 75,343 141,422
Standard errors in parenthesis. ***, **, * represent 1%, 5% and 10% significance, respectively.
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in expenditure from 2007/08 to 2014/15 can, in part, be explained by a change in the distribution in the
age of patients, particularly in the older age groups (60 upwards).14 While the ratio for the relationship
between age and expenditure is positive (coefficient ratio greater than 1) for age groups [10, 20) and [80,
120) it is negative (ratio less than 1) for age groups [40, 70). Taken together (results between dashed
lines), the change in the distribution of age contributes 2.1% to the overall change in expenditures,
whilst the change in the associated coefficients contributes -1.2% to the overall change in expenditure.
Accordingly, in general, the change in the distribution of age has contributed to increasing expenditure
across the two periods (an ageing population), while the change in coefficients has contributed to a
decrease in expenditure (patients more efficiently treated). For the very old (80 years plus), both a
change in the distribution (more elderly patients) and a change in the coefficients both contribute to the
observed growth in expenditures.
The largest single contribution to the change in expenditure is due to the change in coefficients attached
to the constant term (rather than individual demographic variables). In itself, this contributes 6.4% (ratio =
1.0642) to the overall effects of the impact of coefficients (5.2%) and is offset by an overall decrease in the
change in coefficients on the demographic variables (-1.2% for age, sex is not significant). The constant
term estimates the mean of expenditure for the reference category in the regression model (male, aged
[0,5)) around which deviations are estimated for other sex and age categories. The contribution of the
change in coefficients for the constant reflects an increase in average expenditure from 2007/08 to
2014/15. However, while the constant reflects the average expenditure in the reference category, much of
this remains unexplained. Clearly, for model (1) the change in the constant over the period is substantial
reflecting characteristics of patients or the provision of inpatient care not reflected in the set of patient
demographic variables.
Model (7) is the most detailed specification and contains patient characteristics (age and sex), type of
episode (elective - day case, inpatient case; non-elective - short stay, long stay) and associated bed days,
diagnosis, the number of comorbidities and provider type as explanatory variables. Table 4 presents
detailed results for this model using 20 chapters of the ISHMT classification for diagnoses (results using
130 diagnosis groups can be found in Appendix B) and Figure 3 summarizes these results.
The regression results presented in the first two columns in Table 4 show that conditional on information
on episodes, diagnoses and provider type, the impact of sex and age is diminished compared to the
more simple specification presented in Table 3. Indeed, the impact of sex on expenditures becomes
non-significant. The coefficients on age, particularly for age groups of 40 years and above are much
smaller in absolute terms than the corresponding coefficients presented in Table 3. Conditional on the
other explanatory variables, in 2014/15 we observe negative and statistically significant coefficients
for some age groups. This is not unexpected. Howdon and Rice (2017) show that time-to-death is
a stronger predictor of health care expenditures than age, but that time-to-death is itself a proxy for
morbidity. Conditional on measures of morbidity (via diagnoses) it is, therefore, not surprising that age
plays a less crucial role in predicting expenditures. In model (1) the effects ascribed to age are reflecting,
in part, unspecified correlates of age which will include morbidity.
14 Recall from Table 1 that the mean age of patients increases from approximately 50 years in 2004/05 to approximately 52 years in
2014/15.
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Table 4: Blinder-Oaxaca Decomposition of Hospital Costs Difference between 2007/08 and 2014/15
- Specification (7)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
Decomposition (as ratio) 1.0889*** 0.9933 0.9913***
(0.0055) (0.0045) (0.0034)
Decomposition (as ratio) excluding Constant 1.0889 0.9076 0.9913
Male Reference Category 1.0000 1.0005 1.0000
(0.0000) (0.0018) (0.0000)
Female -0.0066 -0.0087 1.0000 0.9994 1.0000
(0.0053) (0.0054) (0.0000) (0.0020) (0.0000)
Sex - total effect 1.0000 0.9999 1.0000
(0.0000) (0.0003) (0.0000)
Age Groups
[0, 5) Reference Category 1.0000 1.0048*** 1.0000
(0.0001) (0.0010) (0.0001)
[5, 10) -0.0138 -0.0240 1.0000 1.0016*** 1.0000
(0.0194) (0.0200) (0.0001) (0.0005) (0.0001)
[10, 20) 0.0458*** 0.0741*** 1.0000 1.0065*** 0.9989***
(0.0151) (0.0163) (0.0001) (0.0009) (0.0002)
[20, 30) -0.0091 -0.0792*** 1.0003*** 1.0005 1.0000
(0.0143) (0.0150) (0.0001) (0.0011) (0.0001)
[30, 40) 0.0107 -0.0764*** 1.0006*** 0.9988 1.0002
(0.0139) (0.0150) (0.0001) (0.0012) (0.0002)
[40, 50) 0.0194 -0.0811*** 1.0001** 0.9970** 1.0001*
(0.0137) (0.0143) (0.0001) (0.0013) (0.0001)
[50, 60) 0.0680*** -0.1077*** 1.0002** 0.9875*** 0.9992***
(0.0137) (0.0142) (0.0001) (0.0013) (0.0002)
[60, 70) 0.1016*** -0.0456*** 1.0007*** 0.9897*** 0.9991***
(0.0136) (0.0141) (0.0001) (0.0014) (0.0002)
[70, 80) 0.1017*** -0.0177 1.0003*** 0.9937*** 0.9998**
(0.0138) (0.0144) (0.0001) (0.0015) (0.0001)
[80, 120) 0.1406*** 0.0715*** 1.0012*** 1.0007 1.0001
(0.0143) (0.0148) (0.0002) (0.0014) (0.0001)
Age - total effect 1.0034*** 0.9807*** 0.9974***
(0.0004) (0.0022) (0.0005)
Episodes
Elective - Day Cases 0.0373*** 0.0626*** 1.0046*** 1.0175*** 1.0031***
(0.0017) (0.0016) (0.0004) (0.0016) (0.0004)
Elective - Inpatient 0.0284*** 0.1786*** 0.9966*** 1.0638*** 0.9821***
(0.0007) (0.0023) (0.0004) (0.0025) (0.0023)
Non-Elective - Short -0.2610*** -0.2558*** 0.9908*** 1.0010 1.0002
Table continues in following page.
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Table 4: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.0056) (0.0054) (0.0007) (0.0014) (0.0003)
Non-Elective - Long 0.2374*** 0.2669*** 1.0260*** 1.0224*** 1.0032***
(0.0026) (0.0025) (0.0021) (0.0028) (0.0005)
Episodes - total effect 1.0178*** 1.1068*** 0.9885***
(0.0023) (0.0050) (0.0024)
Bed Days
Elective 0.0426*** 0.0215*** 0.9953*** 0.9802*** 1.0023***
(0.0006) (0.0004) (0.0013) (0.0008) (0.0007)
Non-Elective 0.0134*** 0.0092*** 1.0027*** 0.9831*** 0.9992***
(0.0003) (0.0003) (0.0010) (0.0015) (0.0003)
Bed Days - total effect 0.9980 0.9636*** 1.0015**
(0.0016) (0.0016) (0.0007)
Diagnoses
First Diagnosis (See Appendix A for descriptions.)
ISHMT0100 0.2573*** 0.1428*** 1.0051*** 0.9974*** 0.9978***
(0.0181) (0.0141) (0.0004) (0.0005) (0.0005)
ISHMT0200 0.6075*** 0.4056*** 1.0065*** 0.9821*** 0.9978***
(0.0104) (0.0103) (0.0010) (0.0013) (0.0004)
ISHMT0300 0.1171*** 0.0415** 1.0004*** 0.9987*** 0.9997**
(0.0200) (0.0189) (0.0001) (0.0005) (0.0001)
ISHMT0400 0.3158*** 0.1352*** 1.0006*** 0.9968*** 0.9996***
(0.0200) (0.0195) (0.0002) (0.0005) (0.0001)
ISHMT0500 -0.1257*** 0.2464*** 0.9982*** 1.0011*** 1.0055***
(0.0474) (0.0217) (0.0007) (0.0002) (0.0008)
ISHMT0600 0.3625*** 0.3056*** 1.0008** 0.9983** 0.9999*
(0.0159) (0.0157) (0.0003) (0.0007) (0.0001)
ISHMT0700 0.1896*** 0.1307*** 1.0004 0.9967*** 0.9999
(0.0124) (0.0126) (0.0002) (0.0010) (0.0001)
ISHMT0800 0.3712*** 0.2849*** 0.9999 0.9991** 1.0000
(0.0255) (0.0265) (0.0002) (0.0004) (0.0000)
ISHMT0900 0.5014*** 0.4890*** 0.9990 0.9987 1.0000
(0.0103) (0.0103) (0.0008) (0.0015) (0.0000)
ISHMT1000 0.3429*** 0.2953*** 1.0045*** 0.9958*** 0.9994***
(0.0108) (0.0105) (0.0006) (0.0013) (0.0002)
ISHMT1100 0.1848*** 0.0587*** 1.0028*** 0.9772*** 0.9981***
(0.0082) (0.0080) (0.0004) (0.0021) (0.0003)
ISHMT1200 0.2714*** 0.1605*** 0.9994** 0.9960*** 1.0002**
(0.0144) (0.0151) (0.0003) (0.0008) (0.0001)
ISHMT1300 0.6500*** 0.4941*** 1.0005 0.9828*** 0.9999
Table continues in following page.
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Table 4: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.0096) (0.0097) (0.0011) (0.0015) (0.0003)
ISHMT1400 0.3052*** 0.3172*** 0.9971*** 1.0012 0.9999
(0.0096) (0.0101) (0.0005) (0.0014) (0.0001)
ISHMT1500 0.1835*** 0.1772*** 0.9985*** 0.9998 1.0000
(0.0165) (0.0192) (0.0002) (0.0008) (0.0002)
ISHMT1600 0.6070*** 0.3503*** 1.0007*** 0.9989*** 0.9997***
(0.0410) (0.0378) (0.0002) (0.0002) (0.0001)
ISHMT1700 0.7685*** 0.6498*** 0.9998 0.9988*** 1.0000
(0.0260) (0.0273) (0.0004) (0.0004) (0.0001)
ISHMT1800 0.1224*** 0.0576*** 1.0005* 0.9887*** 0.9997*
(0.0082) (0.0081) (0.0003) (0.0020) (0.0001)
ISHMT1900 0.5338*** 0.5466*** 1.0011 1.0014 1.0000
(0.0099) (0.0098) (0.0009) (0.0016) (0.0000)
ISHMT2100 0.1779*** 0.1039*** 0.9990*** 0.9957*** 1.0004***
(0.0115) (0.0123) (0.0002) (0.0010) (0.0001)
First Diagnosis - total effect 1.0148*** 0.9088*** 0.9977**
(0.0018) (0.0090) (0.0012)
Comorbidities 0.0750*** 0.0776*** 1.0528*** 1.0032 1.0018
(0.0023) (0.0020) (0.0018) (0.0036) (0.0021)
Type of Provider
Large Provider Reference Category 1.0003 0.9842*** 1.0020***
(0.0005) (0.0044) (0.0006)
Medium Provider -0.0070 0.0118* 1.0003 0.9930** 1.0005*
(0.0064) (0.0070) (0.0002) (0.0035) (0.0003)
Small Provider 0.0043 -0.0085 1.0000 0.9938*** 1.0006***
(0.0088) (0.0096) (0.0001) (0.0016) (0.0002)
Specialist Provider 0.2222*** 0.2026*** 1.0000 0.9982*** 1.0000
(0.0161) (0.0169) (0.0002) (0.0006) (0.0001)
Teaching Provider 0.0740*** 0.0690*** 1.0040*** 0.9892*** 0.9971***
(0.0069) (0.0069) (0.0007) (0.0028) (0.0008)
Other Provider -0.2530*** 0.0302 0.9954*** 1.0005*** 1.0043***
(0.0589) (0.0201) (0.0009) (0.0001) (0.0009)
Type of Provider - total effect 0.9999 0.9595*** 1.0045***
(0.0012) (0.0104) (0.0013)
Constant 6.4940*** 6.6083*** - 1.0857*** -
(0.0133) (0.0137) (0.0150)
Adjusted R-squared 0.6055 0.6182
N 66,079 75,343 141,422
Standard errors in parenthesis. ***, **, * represent 1%, 5% and 10% significance, respectively.
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The impact of type of episode on expenditures differs across the two financial years. For example, the
effect of elective day case episodes on expenditure is 1.7 times greater in 2014/15 than in 2007/08; the
effect of elective inpatient cases is six times greater in 2014/15 than 2007/08; elective bed days attracts
half the effect on expenditure in 2014/15 than in 2007/08; and the impact of non-elective bed days in
2014/15 is 70% of the impact observed in 2007/08. Overall elective stays display a greater positive
relationship with expenditure in 2014/15 than in 2007/08, while bed days (elective and non-elective)
have a reduced role in 2014/15 compared to 2007/08. Non-electives have a similar relationship with
expenditure in both years. Not surprisingly, the regression coefficients attached to the diagnoses dummy
variables are highly statistically significant and positive. The coefficients do, however, vary across the two
financial years - for example, the coefficient for ISHMT1100 (diseases of the digestive system) is 0.1848
in 2007/08 and much reduced at 0.0587 in 2014/15. The impact of comorbidities on log expenditure is
greater in 2014/15 (at 0.0811) than in 2007/08 (at 0.0734). In general, the magnitudes of the effects of
diagnoses outweigh the effects of other coefficients in the model. Of the variables representing provider
type, only specialist, teaching and other providers display a significant relationship with expenditure. For
specialist and teaching their impact on expenditure remains stable across the two periods. For other
providers the effect is negative and statistically significant for expenditure in 2007/08 but small, positive
and not significant in 2014/15.
The final three columns present decomposition results. The first row of Table 4 reproduces the summary
decomposition results reported in Table 2 including significance levels and standard errors, and the
second row shows this decomposition excluding the constant term in the results, which only affects
the results for the Coefficients. The summary results show that the 7.2% increase in expenditure
observed across the two periods can be decomposed into a substantial effect due to a change in the
distribution of characteristics (8.9%) and a marginal contribution due to a change in the relationship
between characteristics and expenditure (overall coefficient effect = -0.7%). The interactions between
these two effects also contributes marginally (-0.9%). It should be noted, however, that the contribution for
a change in coefficients (-0.7%) contains the contribution for a change in the constant. This effect is large
at 8.5% and represents the increase in expenditure across the two periods that remains unexplained
by the set of covariates included in the model. It also implies that there is a large role for a change in
coefficients on the set of explanatory variables to offset the change in the constant. This effect is of
magnitude -9.2% and is substantial, implying efficiency gains in expenditure across at least some of the
set of variables considered. Accordingly, both the distribution of characteristics (leading to an increase in
costs) and the change in coefficients (a change in the constant leading to growth in costs; a change in
coefficients of covariates leading to decreased costs) contribute to the change in expenditures observed
across the period.
From the detailed breakdown of the covariates we can see that the overall change in the distribution of sex
and age play a negligible role in explaining the change in expenditure across the two periods. Similarly
a change in the relationship between sex and expenditures (coefficient effect) is negligible. However,
the impact of a change in the coefficient for age (taken across all age groups) is -2%, suggesting more
efficient treatments for age in 2014/15 compared to 2007/08. This appears to be due mainly to older age
groups ([50, 80)) where coefficient ratios are below 1.
A change in coefficient effects contributes significantly to the change in overall expenditure for elective
patients (both day cases and inpatient care cases). The coefficient on day cases is 1.0175, hence an
increase in the cost of treating day cases contributes 1.8% to the overall 7.2% growth in expenditures.
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The corresponding contribution of a change in the cost of treating elective inpatients is 6.3%. The
role of a change in the distribution (characteristics column) of these two variables in explaining the
change in expenditure is minimal. Long stay non-elective patients contribute to the observed change in
expenditures across the two periods through a change both in the distribution of characteristics and a
change in the effect of these characteristics, with both explaining around 2% of the observed expenditure
change. Accordingly, there appears to have been an increase in non-elective long stay patients coupled
with a higher cost of treatment for such patients. Taken as a whole the impact of a change in the
distribution of episodes contributes approximately 1.8% towards the change in expenditure, while a
change in coefficients is substantial at 10.7%. The former is largely due to an increase in non-elective
long stay patients; the latter is mainly driven by an increase in the cost of treating elective inpatient
stays. The overall effect observed for episodes is partially offset by a decrease in the costs of treating
elective and non-elective bed days (coefficient: 0.9802 for the former and 0.9831 for the latter: an overall
contribution to the change in expenditure of -3.6%). The impact of a change in the distribution of bed
days has a negligible impact on the overall change in expenditure.
The impact of a change in the distribution of diagnoses is approximately 1.5% implying a shift towards
diagnoses which contribute to expenditure growth. However, the overall effect of a change in coefficients
(the relationship between diagnoses and expenditure) is approximately −9.1%, implying greater efficiency
in treating conditions. Notable contributions to the decomposition analysis are observed for ISHMT0200,
ISHMT1100, ISHMT1300 and ISHMT1800 (respectively, neoplasms; diseases of the digestive system;
musculoskeletal system and connective tissue; symptoms, signs and abnormal clinical and laboratory
findings not elsewhere classified).15 For all of these diagnoses a change in the coefficient (the relationship
between diagnosis and expenditure) is negative and statistically significant. However, the change in the
distribution of these diagnoses is positive. Accordingly, while it appears there is a small increase in the
incidence of these diagnoses, this is outweighed by a decrease in the costs of treatment.
A major contributor to the decomposition analysis is the recorded number of comorbidities. While the
contribution of a change in coefficients (relationship with expenditure) is small (1.0032), the change
in characteristics (the distribution of the number of comorbidities) is large (1.0528) and significant
contributing 5.3% to the 7.2% rise in expenditure across the period. This results from an increase in the
average number of reported comorbidities across the two periods. A comparison of models (3) and (4) in
Table 2 provides further insight into the effects of comorbidities. The two models are identical except that
model (4) includes comorbidities. A decomposition of the 7.2% increase in expenditure across the two
periods in model (3) reveals that 4.3% of this is due to a change in characteristics and 2.3% is due to a
change in coefficients (the remainder (0.6%) is due to the interaction of these two effects). A change
in characteristics dominates the change in coefficients. However, when the number of comorbidities is
included, the change in characteristics contributes 11.5% to the overall change in expenditure, with a
change in coefficients contributing negatively (-3.5%). That is, the inclusion of comorbidities places far
greater weight on the impact of characteristics, with coefficients contributing to a lowering of expenditure
across the two periods.
A change in the distribution of patients attending different providers has a negligible effect on the observed
change in expenditure. However, the change in coefficients for providers contributes to lowering costs
across the period by approximately 4.1%. This effect is a combination of a decrease in costs of treating
patients over time in all providers except those designated Other Providers.
15 Notable implying an absolute contribution of greater than 1% to the overall observed change in expenditure across the two periods.
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While the overall summary of the decompositions for model (7) suggests a substantial role for the
change in the distribution of characteristics in explaining the observed change in expenditure, when
considering the detailed results for the individual variables, there are few estimated effects that appear
meaningful. The exceptions are the effects of a change in the distribution of comorbidities which
contributes approximately 5% to the overall result and long stay non-elective patients who contribute
approximately 2.6% to the overall change in expenditures. For both these characteristics, the change in
coefficients is also positive (albeit small for comorbidities). This indicates that these effects have driven
the rise in expenditures through both a characteristic and coefficient effect. However, of the 41 covariates
included in the model, 31 have estimated ratios for characteristics that are equal to or greater than unity.
Accordingly, for the majority of covariates changes in their distribution over time contribute to the growth
in expenditure, even if only marginally. Conversely, for 29 of the 44 covariates the change in coefficients
implies a reduction in expenditures over time. The major contributory factor to the growth in expenditure
among the coefficient effects is attached to the change in the constant term which in itself contributes
8.6%. This effect offsets the reduction in expenditure due to the coefficient effects estimated for the
individual variables (-9.2%), such that the overall coefficient effect contributes less than 1% of the overall
7.2% growth in expenditures. Accordingly, while many covariates indicate more efficient delivery of health
care over time, this is offset by the unexplained change in the constant.
Provider
Comorbidities
First Diagnosis
Bed Days
Episodes
Age
Sex
V
ar
ia
bl
es
.9 .95 1 1.05 1.1
Decomposition (as ratio)
Characteristics Coefficients
Figure 3: Summary of Table 4
Figure 3 summarizes the results shown in Table 4. For each group of variables it shows the estimate
(with confidence interval) of the decomposition into Characteristics and Coefficients. The vertical line at
1 indicates no effect, i.e. estimates which confidence interval cross this line are not significant.
6.2. Decomposition of the full distribution of expenditures
Table 5 shows the results based on the decomposition method of Chernozhukov et al. (2013) using the
same data and specification (model 7) as for the Oaxaca Decomposition.16 The approach allows the
16 We implement this approach using the Stata command cdeco.
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change in expenditures to be decomposed across the full distribution, rather than focusing on the change
in expenditures at the mean. This is achieved by estimating the counterfactual distribution using the
conditional distribution, FY (y|x), in one group and the distribution of independent variables (FX(x)) of
the other group. For the two periods of HES data, the decomposition is set out in Equation (4), where
the index 1 denotes the year 2014/15 and 0 the year 2007/08. To simplify presentation, Table 5 reports
the difference in observed outcomes and the decomposition at the deciles of the distribution. These
are calculated on a log scale. A more detailed breakdown of the results estimated at each percentile is
illustrated in Figure 4.
Table 5: Counterfactual Decomposition of Differences in Distributions - Log(Hospital Costs) between
2007/08 and 2014/15
Quantile Differences between
the observable
distributions
Effects of
characteristics
Effects of coefficients
0.1 -0.106 -0.004 -0.102
[-0.119, -0.093] [-0.010, 0.002] [-0.113, -0.090]
0.2 -0.045 0.002 -0.047
[-0.056, -0.033] [-0.004, 0.008] [-0.057, -0.036]
0.3 0.014 0.013 0.000
[0.002, 0.025] [0.007, 0.019] [-0.009, 0.010]
0.4 0.056 0.022 0.035
[0.044, 0.069] [0.015, 0.028] [0.026, 0.044]
0.5 0.085 0.026 0.060
[0.073, 0.098] [0.019, 0.032] [0.051, 0.069]
0.6 0.104 0.030 0.074
[0.091, 0.117] [0.023, 0.038] [0.065, 0.082]
0.7 0.121 0.042 0.078
[0.106, 0.135] [0.032, 0.052] [0.070, 0.087]
0.8 0.146 0.078 0.068
[0.124, 0.168] [0.064, 0.093] [0.053, 0.083]
0.9 0.211 0.177 0.034
[0.172, 0.250] [0.152, 0.203] [-0.001, 0.068]
N 2007/08 66,079
N 2014/15 75,343
Pointwise Confidence Interval in parenthesis.
The first two quantiles of Table 5 show an overall negative change in expenditures (a decrease in
expenditure from 2007/08 to 2014/15). The change is then positive and increasing in magnitude
thereafter (an observed growth in expenditure). Larger increases are observed at the top of the
expenditure distribution. That is, expensive to treat patients have raised expenditure disproportionately
more than less expensive patients. All of the observed effects are statistically significant (none of the
confidence intervals straddle zero). The final two columns show the decomposition results for the effect
of a change in characteristics and the effect for a change in coefficients. Again, from the 30th quantile
upwards, these effects are positive and statistically significant implying their contribution increases
expenditures. In general the changes in expenditure across the quantiles are driven by a change in
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coefficients rather than a change in characteristics (coefficient effects have higher absolute values than
the effect of characteristics).17 For high expenditure patients (80th and 90th quantile) the effect of a
change in characteristics is more important in explaining the rise in expenditure than the effect for a
change in coefficients. This is particularly evident at the 90th quantile. The increase in expenditure at the
top of the distribution is driven largely by changes in the composition of patients. At the bottom of the
distribution coefficient effects dominate the effects of characteristics implying that expenditure savings
over the two periods are driven by more efficient treatment of patients. In the middle of the distribution,
again the effect of coefficients dominates characteristics. However, here both effects contribute to
increasing, rather than decreasing expenditures.
To better understand the decomposition results across the full distribution, Table 6 summarises the
differences in the key covariates of the model across the two time periods broken down into the bottom
10%, the middle (10th to 90th percentile), and the top 10% of the expenditure distribution in each year.
This illustrates the large increase in expenditure at the top end of the distribution (4,142.6) compared
to other parts of the distribution (-41.9 in the bottom 10% and 289.3 in the middle of the distribution).
While the average age of patients treated decreased in the lower part of the expenditure distribution,
they increased more substantially in the middle compared to the top of the distribution. The number of
comorbidities and the number of first diagnoses increase across the two periods to a greater extent at
the top of the expenditure distribution than in other areas of the distribution. This emphasises the role of
comorbidity in driving expenditure increases. Other notable increases that are particularly pronounced at
the top of the distribution are the number of episodes per patient, particularly the average number of
non-elective episodes.18 The number of non-elective episodes per patient increased on average by 0.92,
while the average number of non-elective bed days per patient increased by 2.47 across the period in the
top 10% of the expenditure distribution. Compared to the middle of the distribution (where for example,
non-elective bed days decrease), these increases are notable.
Figure 4 plots the overall change in expenditures together with the effects of coefficients and characterist-
ics across the full expenditure distribution. For the majority of the distribution (to the 80th quantile), the
plotted lines for the observed change in expenditures and the coefficients effects overlap emphasising the
strong contribution of coefficients to the overall change. In contrast, the plot for the effects of a change in
characteristics across the quintile distribution is close to zero, except at the top of the distribution (80th
quantile onwards) where they closely align to the plot for the overall change in expenditures.
17 Note that for model 7, the Oaxaca decomposition at the mean showed a larger role for the effects of a change in characteristics
rather than a change in coefficients.
18 Note that the average number of elective episodes decreases between 2007/08 and 2014/15 at the top of the distribution, due to a
shift from inpatient to daycase care.
The determinants of health care expenditure growth 27
Table 6: Differences in Mean between 2007/08 and 2014/15
Bottom Middle Top
10% [10th - 90th pctile] 10%
Diff.Mean StdErr Diff.Mean StdErr Diff.Mean StdErr
Cost (in £ of 2007/08) -41.86 0.93 289.26 10.37 4142.57 199.77
Demographics
Age -3.56 0.40 2.33 0.15 1.58 0.36
Male -0.0309 0.0084 0.0042 0.0030 -0.0084 0.0084
Morbidity
Num. different 1st diagnoses
based in 20 ISHMT chapters 0.00 0.00 0.05 0.00 0.25 0.02
based in 130 ISHMT groups 0.00 0.00 0.06 0.00 0.30 0.02
Number of Comorbidities ? 0.27 0.02 0.66 0.01 1.35 0.04
Activity
Total Episodes 0.00 0.00 0.15 0.01 0.25 0.17
Elective Episodes -0.01 0.01 0.09 0.01 -0.66 0.17
Daycases -0.02 0.01 0.11 0.01 0.36 0.08
Inpatient 0.00 0.00 -0.02 0.00 -1.02 0.15
Non-Elective Episodes 0.02 0.01 0.06 0.01 0.92 0.06
Short Stay 0.02 0.01 0.03 0.00 0.06 0.01
Long Stay 0.00 0.00 0.03 0.01 0.85 0.05
Bed Days 0.07 0.05 -0.21 0.03 2.47 0.58
Elective 0.03 0.01 -0.14 0.01 0.00 0.28
Non-Elective 0.05 0.05 -0.06 0.03 2.47 0.54
Provider Type
Large Provider -0.0373 0.0081 -0.0469 0.0028 -0.0472 0.0079
Medium Provider -0.0247 0.0075 -0.0203 0.0026 -0.0196 0.0072
Small Provider -0.0014 0.0053 -0.0121 0.0018 -0.0063 0.0050
Specialist Provider 0.0016 0.0017 -0.0001 0.0010 -0.0029 0.0031
Teaching Provider 0.0473 0.0072 0.0618 0.0026 0.0526 0.0076
Other Provider 0.0144 0.0016 0.0176 0.0006 0.0233 0.0020
Num. Obs. 2007/08 6,607 52,864 6,608
Num. Obs. 2014/15 7,534 60,274 7,535
?based on 130 ISHMT groups.
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Figure 4: Counterfactual Decomposition of Differences in Distributions - Log(Hospital Costs) between
2007/08 and 2014/15
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7. Discussion
This paper considers the detailed breakdown of hospital inpatient expenditures across the period 2007/08
to 2014/15. Decomposition techniques are used to unpick the observed growth in expenditure into
components due to a change in the distribution of characteristics (for example, greater prevalence of
morbidity measured via diagnostic categories) and due to a change in the impact of such characteristics
on expenditures (coefficient effects). We undertake this analysis by randomly sampling 1% of the
population of hospital inpatient users in each of the two years. The overall growth in expenditure per
patient from 2007/08 to 2014/15 was £641.60, representing a 21.6% (7.23% on the log scale) increase
over the period.
For the most saturated model (model (7); Table 4) we observe statistically significant relationships with
expenditure due to age, type of episode (elective - day cases; elective - inpatient; non-elective - short;
non-elective - long), bed days, diagnoses, the number of comorbidities, and certain types of provider
(specialist, teaching). The majority of the characteristics are specified as dummy variables and, hence,
coefficients can be readily compared. In general, the magnitude of effects for diagnoses outweighs
effects for other coefficients in the model in explaining expenditure.
The decomposition analysis shows that the increase in (log) expenditure observed across the two periods
can be decomposed into a substantial effect due to a change in the distribution of characteristics and
a marginal contribution due to a change in the relationship between characteristics and expenditure.
It should be noted, however, that the contribution of a change in coefficients contains the contribution
of a change in the constant term. This effect is large, almost as large as the effect due to a change in
the distribution of characteristics, and represents the increase in expenditure across the two periods
that remains unexplained by the set of covariates included in the model. It also implies that there is a
large role for a change in coefficients on the set of explanatory variables to offset the change in the
constant, implying efficiency gains in expenditure across at least some of the set of variables considered.
Accordingly, both the distribution of characteristics (leading to an increase in costs) and the change in
coefficients (constant leading to an increase in costs; covariates to a decrease in costs) contribute to the
change in expenditures observed across the period.
Overall, sex and age play a negligible role (both in a change in characteristics and change in coefficients)
in explaining the increase in expenditure across the two periods. Expenditure on elective inpatient care
(both day cases and inpatient care cases) has risen, mainly due to an increase in treatment costs rather
than a structural change in a shift towards elective treatments. Similarly expenditure on non-elective
long stay episodes has increased, due to both an increase in such cases together with an increase
in the relationship with expenditure. The overall impact of a change in the distribution of diagnoses
implies a modest shift towards diagnoses which contribute to increased expenditure. The corresponding
overall effect of a change in coefficients (the relationship between diagnoses and expenditure), on the
other hand, implies greater efficiency in treating conditions. This is particularly the case for neoplasms
(ISHMT0200), diseases of the digestive system (ISHMT1100), musculoskeletal system and connective
tissue (ISHMT1300) and symptoms, signs and abnormal clinical and laboratory findings not elsewhere
classified (ISHMT1800).
A major contributor to the decomposition analysis is the recorded number of comorbidities. The effect of
a structural change in the distribution of the number of comorbidities is large and significant, contributing
more than half of the overall rise in expenditure due to all characteristics across the period. This results
from an increase in the average number of reported comorbidities. Aragón et al. (2016) document
CHE Research Paper 156 30
the rise in the average number of comorbidities reported in Hospital Episode Statistics over the period
1998/99 to 2012/13. They note the consistent increase in the number of reported comorbidities over the
period from around an average of 0.2 for women and 0.3 for men in 1998/99 to approximately 0.3 and
0.4 respectively at the end of the series. They also document the increased expenditures associated
with comorbidities - in 2012/13 the difference in average expenditure for patients recorded without a
comorbidity and with a single comorbidity was £1,790; the difference in average expenditure for patients
with 1 and 2 comorbidities was £3,478; between 2 and 3, £4,096; between 3 and 4, £4,677 and between
4 and 4+ £6,133. Clearly comorbidities are more complex and expensive to treat. The observed increase
in comorbidity may help to explain the observed rise in activity (episodes of care). However, it is important
to note that the recording of diagnoses changed between the two years considered in this analysis, which
likely led to an increase in the number of comorbidities documented in HES (refer to footnote 7).
While the overall summary of the decompositions for the most detailed model (model (7)) suggests a
substantial role for a structural change in the distribution of characteristics in explaining the observed
change in expenditure, the detailed results sugest few individual characteristics that appear meaning-
ful. The exceptions are the effects of a change in the distribution of comorbidities which contributes
approximately 5.3% and long stay non-elective patients contributing approximately 2.6% to the overall
change in expenditures. For both these characteristics, the change in the relationship with expenditure
is also positive (albeit small for comorbidities). This indicates that these effects have driven the rise in
expenditures through both a structural characteristic and coefficient effect.
When considering the full distribution of expenditures, we observe a negative change at the bottom of the
distribution (bottom two quintiles) but increasing expenditure thereafter. Large increases are observed at
the top of the expenditure distribution. Here, the effect of changes in characteristics are more important
in explaining the rise in expenditures than the effects for a change in coefficients. These changes appear
due to increases in comorbidities (and the average number of first diagnoses) across the two periods,
together with increases in non-elective long stay episodes and non-elective bed days.
The results of this analysis needs to be placed within the context of broader economic constraints within
which the NHS operates. Decisions to access and consume health care resources is not simply based on
the needs of patients. Decisions about the allocation of resources across disease groups and individuals
are implicitly made within a budget constraint. Accordingly the level of overall sickness or ill-health within
the population is not the only major determinant of aggregate health care expenditure. Population ageing,
increased duration of time spent with chronic conditions, and multi-morbidity will all lead to shifts in the
way health care expenditure is determined and allocated, but so will political preferences and economic
growth which influence funding levels and the organisation of health care provision (see for example,
Getzen (2001)). While comparing the determinants of expenditure across periods is not straightforward
in any dynamic system, the decomposition analysis employed helps elucidate effects due to changes in
the distribution of drivers and changes in how a given characteristic, such as given diagnosis, is treated.
The techniques further allow investigation of where in the distribution of expenditures these effects are
most prominent and where expenditure rises have been most notable.
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A. Appendix A
Table A.1 shows the descriptions of the 20 ISHMT chapters used to classify diagnoses in the main part.
For a description of the groups within each chapter see http://www.who.int/classifications/icd/
implementation/morbidity/ishmt/en/.
Table A.1: ISHMT Classification
ISHMT Code Heading ICD Codes
0100 Certain infectious and parasitic diseases A00 - B99
0200 Neoplasms C00 - D48
0300 Diseases of the blood and bloodforming organs and certain disorders
involving the immune mechanism
D50 - D89
0400 Endocrine, nutritional and metabolic diseases E00 - E90
0500 Mental and behavioural disorders F00 - F99
0600 Diseases of the nervous system G00 - G99
0700 Diseases of the eye and adnexa H00 - H59
0800 Diseases of the ear and mastoid process H60 - H95
0900 Diseases of the circulatory system I00 - I99
1000 Diseases of the respiratory system J00 - J99
1100 Diseases of the digestive system K00 - K93
1200 Diseases of the skin and subcutaneous tissue L00 - L99
1300 Diseases of the musculoskeletal system and connective tissue M00 - M99
1400 Diseases of the genitourinary system N00 - N16
1500 Pregnancy, childbirth and the puerperium O00 - O99
1600 Certain conditions originating in the perinatal period P00 - P96
1700 Congenital malformations, deformations and chromosomal abnormalit-
ies
Q00 - Q99
1800 Symptoms, signs and abnormal clinical and laboratory findings, not
elsewhere classified
R00 - R99
1900 Injury, poisoning and certain other consequences of external causes S00 - T98
2100 Factors influencing health status and contact with health services Z00 - Z99
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B. Appendix B
This section presents results using the 130 diagnosis groups in ISHMT rather than the 20 chapters used
in Table 4 (see Section B.1) and Table 5 and Figure 4 (see Section B.2).
B.1. Oaxaca
Table B.1: Blinder-Oaxaca Decomposition of Hospital Costs Difference between 2007/08 and
2014/15 - Reference Group: 2007/08 - Specification (7) - 130 diagnosis groups
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
Decomposition (as ratio) 1.0916*** 0.9939 0.9883***
(0.0058) (0.0041) (0.0033)
Decomposition (as ratio) excluding Constant 1.0916 0.0584 0.9883
Male Reference Category 1.0000 1.0012 1.0000
(0.0000) (0.0017) (0.0000)
Female -0.0205*** -0.0255*** 1.0000 0.9986 1.0000
(0.0051) (0.0052) (0.0000) (0.0020) (0.0000)
Sex - total effect 1.0000 0.9998 1.0000
(0.0001) (0.0002) (0.0000)
Age Groups
[0, 5) Reference Category 1.0000 1.0046*** 1.0000
(0.0000) (0.0010) (0.0001)
[5, 10) -0.0315* -0.0401** 1.0000 1.0016*** 1.0000
(0.0181) (0.0190) (0.0000) (0.0005) (0.0001)
[10, 20) 0.0465*** 0.0619*** 0.9997*** 1.0055*** 0.9991***
(0.0144) (0.0157) (0.0001) (0.0009) (0.0002)
[20, 30) -0.0300** -0.1150*** 1.0003*** 0.9988 1.0001
(0.0137) (0.0146) (0.0001) (0.0011) (0.0001)
[30, 40) -0.0182 -0.1149*** 1.0006*** 0.9974** 1.0004**
(0.0134) (0.0146) (0.0001) (0.0011) (0.0002)
[40, 50) -0.0098 -0.1094*** 1.0001** 0.9967*** 1.0001*
(0.0132) (0.0140) (0.0001) (0.0012) (0.0001)
[50, 60) 0.0186 -0.1413*** 1.0000 0.9891*** 0.9993***
(0.0132) (0.0139) (0.0001) (0.0012) (0.0002)
[60, 70) 0.0419*** -0.0883*** 1.0003*** 0.9917*** 0.9993***
(0.0131) (0.0138) (0.0001) (0.0013) (0.0002)
[70, 80) 0.0503*** -0.0537*** 1.0002** 0.9954*** 0.9998**
(0.0133) (0.0142) (0.0001) (0.0014) (0.0001)
[80, 120) 0.1105*** 0.0583*** 1.0012*** 1.0024* 1.0003*
(0.0.138) (0.0146) (0.0002) (0.0013) (0.0001)
Age - total effect 1.0024*** 0.9833*** 0.9984***
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.0003) (0.0022) (0.0005)
Episodes
Elective - Day Cases 0.0347*** 0.0559*** 1.0043*** 1.0146*** 1.0026***
(0.0016) (0.0016) (0.0004) (0.0015) (0.0003)
Elective - Inpatient 0.0278*** 0.1457*** 0.9967*** 1.0491*** 0.9859***
(0.0007) (0.0022) (0.0004) (0.0021) (0.0018)
Non-Elective - Short -0.2418*** -0.2417*** 0.9915*** 1.0000 1.0000
(0.0054) (0.0053) (0.0007) (0.0014) (0.0003)
Non-Elective - Long 0.2231*** 0.2507*** 1.0244*** 1.0209*** 1.0030***
(0.0026) (0.0025) (0.0020) (0.0028) (0.0005)
Episodes - total effect 1.0167*** 1.0868*** 0.9915***
(0.0021) (0.0047) (0.0019)
Bed Days
Elective 0.0341*** 0.0192*** 0.9963*** 0.9860*** 1.0016***
(0.0005) (0.0004) (0.0010) (0.0007) (0.0005)
Non-Elective 0.0113*** 0.0076*** 1.0023*** 0.9847*** 0.9992***
(0.0003) (0.0002) (0.0008) (0.0014) (0.0003)
Bed Days - total effect 0.9985 0.9709*** 1.0009
(0.0013) (0.0016) (0.0006)
Diagnoses
First Diagnosis
ISHMT1 0.2201*** 0.1502*** 0.9999 0.9995 1.0000
(0.0295) (0.0317) (0.0001) (0.0003) (0.0000)
ISHMT2 0.2856*** 0.0088 1.0039*** 0.9997*** 0.9962***
(0.0750) (0.0209) (0.0010) (0.0001) (0.0011)
ISHMT3 0.8457*** 0.6799*** 0.9996*** 0.9999 1.0001
(0.0862) (0.1442) (0.0001) (0.0001) (0.0001)
ISHMT4 0.1723*** 0.0812*** 1.0006*** 0.9997* 0.9997*
(0.0397) (0.0297) (0.0002) (0.0002) (0.0002)
ISHMT5 0.7497*** (omitted) 0.9997*** 0.9997*** 1.0003***
(0.1112) (0.0001) (0.0001) (0.0001)
ISHMT6 0.2714*** 0.2233*** 1.0013*** 0.9995 0.9998
(0.0235) (0.0211) (0.0002) (0.0003) (0.0002)
ISHMT7 0.9466*** 0.7484*** 0.9998 0.9988*** 1.0000
(0.0311) (0.0327) (0.0004) (0.0003) (0.0001)
ISHMT8 0.7879*** 0.5171*** 0.9998 0.9986*** 1.0001
(0.0332) (0.0353) (0.0003) (0.0003) (0.0001)
ISHMT9 0.1728*** 0.0488** 1.0007*** 0.9987*** 0.9995***
(0.0234) (0.0210) (0.0001) (0.0003) (0.0001)
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
ISHMT10 1.1246*** 0.9448*** 0.9999 0.9987*** 1.0000
(0.0281) (0.0300) (0.0005) (0.0003) (0.0001)
ISHMT11 0.8989*** 0.9344*** 1.0000 1.0001 1.0000
(0.0623) (0.0642) (0.0002) (0.0001) (0.0000)
ISHMT12 1.0109*** 0.6824*** 1.0001 0.9996*** 1.0000
(0.0652) (0.0663) (0.0002) (0.0001) (0.0001)
ISHMT13 0.5941*** 0.4313*** 1.0005** 0.9993*** 0.9999*
(0.0364) (0.0348) (0.0002) (0.0002) (0.0001)
ISHMT14 0.5501*** 0.4868*** 0.9992*** 0.9996 1.0001
(0.0320) (0.0386) (0.0002) (0.0003) (0.0001)
ISHMT15 0.8503*** 0.6684*** 1.0026*** 0.9959*** 0.9994***
(0.0172) (0.0174) (0.0007) (0.0006) (0.0002)
ISHMT16 0.4025*** 0.2634*** 1.0002 0.9996** 0.9999
(0.0454) (0.0437) (0.0001) (0.0002) (0.0001)
ISHMT17 0.0183 -0.1115*** 1.0001 0.9994*** 0.9991***
(0.0350) (0.0236) (0.0002) (0.0002) (0.0003)
ISHMT18 0.7179*** 0.7119*** 0.9996* 1.0000 1.0000
(0.0388) (0.0436) (0.0002) (0.0002) (0.0000)
ISHMT19 0.3214*** 0.2329*** 0.9998 0.9983*** 1.0001
(0.0175) (0.0186) (0.0002) (0.0005) (0.0001)
ISHMT20 0.1067*** 0.0293 1.0004*** 0.9989*** 0.9997**
(0.0208) (0.0192) (0.0001) (0.0004) (0.0001)
ISHMT21 0.2798*** 0.2568*** 0.9999 0.9999 1.0000
(0.0371) (0.0399) (0.0001) (0.0002) (0.0000)
ISHMT22 0.2831*** 0.2441*** 0.9996*** 0.9998 1.0001
(0.0305) (0.0364) (0.0001) (0.0003) (0.0001)
ISHMT23 0.3979*** 0.1637*** 1.0014*** 0.9972*** 0.9992***
(0.0223) (0.0205) (0.0003) (0.0004) (0.0002)
ISHMT24 -0.6625*** 0.2312*** 0.9989*** 1.0003*** 1.0015***
(0.1272) (0.0556) (0.0002) (0.0001) (0.0003)
ISHMT25 -0.3972*** 0.3066*** 0.9987*** 1.0009*** 1.0024***
(0.0670) (0.0373) (0.0002) (0.0001) (0.0003)
ISHMT26 1.3321*** 0.2967*** 1.0011*** 1.0000 0.9992***
(0.3555) (0.0848) (0.0003) (0.0000) (0.0003)
ISHMT27 0.6937*** 0.3972*** 1.0017*** 1.0000 0.9993
(0.2046) (0.0518) (0.0005) (0.0000) (0.0005)
ISHMT28 0.0421 0.4383*** 1.0001 1.0001** 1.0009**
(0.1502) (0.0498) (0.0004) (0.0000) (0.0004)
ISHMT29 0.4153*** 0.3435*** 1.0021*** 0.9999 0.9996
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.0751) (0.0323) (0.0004) (0.0001) (0.0004)
ISHMT30 0.1937** 0.7001*** 0.9999* 1.0004*** 0.9998**
(0.0872) (0.1259) (0.0000) (0.0001) (0.0001)
ISHMT31 0.6849*** 1.0468*** 1.0001 1.0004*** 1.0001
(0.0699) (0.0674) (0.0001) (0.0001) (0.0001)
ISHMT32 0.4664*** 0.3013*** 0.9997* 0.9992*** 1.0001*
(0.0355) (0.0400) (0.0002) (0.0002) (0.0001)
ISHMT33 0.1249*** 0.1348*** 1.0000 1.0000 1.0000
(0.0431) (0.0439) (0.0000) (0.0002) (0.0000)
ISHMT34 0.4034*** 0.3014*** 1.0012*** 0.9980*** 0.9997***
(0.0174) (0.0169) (0.0003) (0.0005) (0.0001)
ISHMT35 0.1969*** 0.0385*** 1.0000 0.9943*** 1.0000
(0.0137) (0.0142) (0.0002) (0.0007) (0.0002)
ISHMT36 0.2319*** 0.2978*** 1.0004** 1.0014*** 1.0001*
(0.0168) (0.0169) (0.0002) (0.0005) (0.0001)
ISHMT37 0.3648*** 0.2723*** 0.9999 0.9990*** 1.0000
(0.0235) (0.0247) (0.0002) (0.0004) (0.0001)
ISHMT38 0.1266*** 0.0833 0.9998** 0.9999 1.0001
(0.0433) (0.0612) (0.0001) (0.0002) (0.0001)
ISHMT39 0.1555*** 0.1264*** 0.9992*** 0.9997 1.0001
(0.0232) (0.0314) (0.0001) (0.0005) (0.0002)
ISHMT40 0.4595*** 0.6002*** 1.0000 1.0015*** 1.0000
(0.0243) (0.0254) (0.0003) (0.0004) (0.0001)
ISHMT41 0.7076*** 0.5908*** 0.9989** 0.9980*** 1.0002**
(0.0193) (0.0207) (0.0005) (0.0005) (0.0001)
ISHMT42 0.4153*** 0.4218*** 1.0005*** 1.0000 1.0000
(0.0435) (0.0379) (0.0001) (0.0002) (0.0001)
ISHMT43 0.4479*** 0.4303*** 1.0001 0.9997 1.0000
(0.0188) (0.0193) (0.0003) (0.0005) (0.0000)
ISHMT44 0.2955*** 0.2503*** 1.0001 0.9996 1.0000
(0.0266) (0.0270) (0.0001) (0.0003) (0.0000)
ISHMT45 0.7686*** 0.8144*** 0.9999 1.0006 1.0000
(0.0213) (0.0221) (0.0005) (0.0004) (0.0000)
ISHMT46 0.6415*** 0.6906*** 1.0004*** 1.0001 1.0000
(0.0704) (0.0592) (0.0001) (0.0001) (0.0001)
ISHMT47 0.5503*** 0.3778*** 0.9995*** 0.9991*** 1.0002**
(0.0333) (0.0384) (0.0002) (0.0003) (0.0001)
ISHMT48 0.3510*** 0.2873*** 1.0011*** 0.9983*** 0.9998**
(0.0152) (0.0150) (0.0003) (0.0006) (0.0001)
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
ISHMT49 0.2670*** 0.1772*** 0.9999 0.9984*** 1.0000
(0.0194) (0.0203) (0.0002) (0.0005) (0.0001)
ISHMT50 0.3487*** 0.2641*** 1.0041*** 0.9984*** 0.9990***
(0.0182) (0.0157) (0.0004) (0.0005) (0.0003)
ISHMT51 0.2823*** 0.2624*** 1.0009*** 0.9997 0.9999
(0.0199) (0.0190) (0.0002) (0.0004) (0.0001)
ISHMT52 0.4371*** 0.3131*** 0.9997** 0.9995** 1.0001
(0.0395) (0.0454) (0.0001) (0.0002) (0.0001)
ISHMT53 0.4794*** 0.4423*** 0.9998 0.9997 1.0000
(0.0249) (0.0264) (0.0002) (0.0003) (0.0000)
ISHMT54 0.2594*** 0.1714*** 1.0005*** 0.9990*** 0.9998**
(0.0231) (0.0225) (0.0002) (0.0004) (0.0001)
ISHMT55 0.2198*** 0.2562*** 0.9998 1.0003 1.0000
(0.0272) (0.0295) (0.0001) (0.0003) (0.0000)
ISHMT56 0.4056*** 0.3142*** 1.0007*** 0.9991*** 0.9998**
(0.0249) (0.0239) (0.0002) (0.0003) (0.0001)
ISHMT57 0.0026 -0.0841*** 1.0000 0.9977*** 0.9999
(0.0156) (0.0160) (0.0000) (0.0006) (0.0001)
ISHMT58 0.1798*** -0.1437*** 1.0002** 0.9988*** 0.9997***
(0.0385) (0.0357) (0.0001) (0.0002) (0.0001)
ISHMT59 -0.0809*** -0.2216*** 0.9997*** 0.9974*** 0.9995***
(0.0178) (0.0170) (0.0001) (0.0005) (0.0001)
ISHMT60 0.1182*** 0.0041 0.9999* 0.9994** 1.0001
(0.0343) (0.0387) (0.0001) (0.0003) (0.0001)
ISHMT61 -0.1122*** -0.2568*** 0.9993*** 0.9973*** 0.9990***
(0.0178) (0.0161) (0.0001) (0.0005) (0.0002)
ISHMT62 0.9671*** 1.0283*** 1.0005 1.0003 1.0000
(0.0328) (0.0326) (0.0004) (0.0002) (0.0000)
ISHMT63 0.5658*** 0.5955*** 0.9986*** 1.0003 0.9999
(0.0227) (0.0265) (0.0003) (0.0004) (0.0001)
ISHMT64 0.2986*** 0.2153*** 1.0003* 0.9990*** 0.9999
(0.0223) (0.0224) (0.0002) (0.0004) (0.0001)
ISHMT65 0.3375*** 0.3503*** 1.0008*** 1.0001 1.0000
(0.0294) (0.0267) (0.0002) (0.0003) (0.0001)
ISHMT66 0.1060*** -0.0492 0.9988*** 0.9975*** 1.0018***
(0.0194) (0.0377) (0.0002) (0.0007) (0.0005)
ISHMT67 0.5208*** 0.3471*** 1.0005*** 0.9995*** 0.9998**
(0.0443) (0.0401) (0.0002) (0.0002) (0.0001)
ISHMT68 0.0591** -0.0655*** 1.0002** 0.9987*** 0.9996***
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.0236) (0.0217) (0.0001) (0.0003) (0.0001)
ISHMT69 0.1455*** 0.0739*** 0.9995*** 0.9988** 1.0003**
(0.0187) (0.0218) (0.0001) (0.0005) (0.0001)
ISHMT70 0.1353*** 0.0370** 1.0009*** 0.9986*** 0.9994***
(0.0203) (0.0176) (0.0002) (0.0004) (0.0002)
ISHMT71 0.4876*** 0.3153*** 1.0000 0.9997* 1.0000
(0.0618) (0.0631) (0.0001) (0.0001) (0.0000)
ISHMT72 0.4052*** 0.1034** 1.0003** 0.9995*** 0.9998**
(0.0577) (0.0511) (0.0001) (0.0001) (0.0001)
ISHMT73 0.7561*** 0.6918*** 1.0011*** 0.9993* 0.9999
(0.0234) (0.0230) (0.0004) (0.0004) (0.0001)
ISHMT74 0.3847*** 0.2964*** 1.0003** 0.9996* 0.9999
(0.0380) (0.0364) (0.0001) (0.0002) (0.0001)
ISHMT75 0.4681*** 0.3526*** 1.0006*** 0.9997* 0.9999*
(0.0440) (0.0387) (0.0002) (0.0002) (0.0001)
ISHMT76 0.2162*** 0.0182 1.0012*** 0.9978*** 0.9989***
(0.0235) (0.0198) (0.0002) (0.0003) (0.0002)
ISHMT77 0.0856*** 0.0327 0.9999** 0.9997 1.0001
(0.0300) (0.0358) (0.0001) (0.0003) (0.0001)
ISHMT78 0.3533*** 0.1826*** 0.9999 0.9996** 1.0001
(0.0486) (0.0542) (0.0001) (0.0002) (0.0000)
ISHMT79 03341*** 0.2062*** 0.9999 0.9964*** 1.0000
(0.0150) (0.0156) (0.0003) (0.0006) (0.0001)
ISHMT80 1.4094*** 1.1943*** 1.0005 0.9984*** 0.9999
(0.0278) (0.0272) (0.0007) (0.0003) (0.0001)
ISHMT81 1.1299*** 1.1659*** 0.9964*** 1.0005 0.9999
(0.0210) (0.0248) (0.0007) (0.0004) (0.0001)
ISHMT82 0.7126*** 0.5867*** 0.9986*** 0.9987*** 1.0002**
(0.0242) (0.0273) (0.0004) (0.0004) (0.0001)
ISHMT83 0.6003*** 0.4962*** 1.0007 0.9971*** 0.9999
(0.0150) (0.0154) (0.0005) (0.0006) (0.0001)
ISHMT84 0.6150*** 0.4738*** 1.0003** 0.9999 0.9999
(0.0733) (0.0648) (0.0001) (0.0001) (0.0000)
ISHMT85 0.5586*** 0.2782*** 1.0011*** 0.9984*** 0.9995***
(0.0317) (0.0287) (0.0002) (0.0003) (0.0001)
ISHMT86 0.6819*** 0.2799*** 1.0003 0.9977*** 0.9998
(0.0315) (0.0318) (0.0003) (0.0003) (0.0002)
ISHMT87 0.1998*** 0.0755*** 1.0001 0.9982*** 0.9999
(0.0202) (0.0208) (0.0001) (0.0004) (0.0001)
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
ISHMT88 0.3645*** 0.2872*** 1.0000 0.9981*** 1.0000
(0.0157) (0.0163) (0.0003) (0.006) (0.0001)
ISHMT89 0.6281*** 0.3417*** 1.0013*** 0.9980*** 0.9994***
(0.0289) (0.0265) (0.0003) (0.0003) (0.0002)
ISHMT90 0.3525*** 0.4006*** 1.0009*** 1.0002 1.0001
(0.0333) (0.0288) (0.0002) (0.0002) (0.0001)
ISHMT91 0.1251*** 0.1354*** 1.0002*** 1.0001 1.0000
(0.0316) (0.0277) (0.0001) (0.0003) (0.0001)
ISHMT92 0.4529*** 0.4154*** 1.0000 0.9997 1.0000
(0.0286) (0.0300) (0.0002) (0.0003) (0.0000)
ISHMT93 0.2285*** 0.2116*** 1.0004* 0.9995 1.0000
(0.0142) (0.0146) (0.0002) (0.0006) (0.0000)
ISHMT94 0.3004*** 0.4168*** 0.9996*** 1.0006** 0.9999*
(0.0341) (0.0411) (0.0001) (0.0003) (0.0001)
ISHMT95 0.1678*** 0.2007*** 0.9999 1.0004 1.0000
(0.0232) (0.0248) (0.0001) (0.0004) (0.0000)
ISHMT96 0.5659*** 0.4150*** 0.9995*** 0.9995** 1.0001*
(0.0427) (0.0526) (0.0002) (0.0002) (0.0001)
ISHMT97 0.4394*** 0.5390*** 0.9999 1.0003 1.0000
(0.0435) (0.0474) (0.0001) (0.0002) (0.0000)
ISHMT98 0.2602*** 0.2687*** 0.9987*** 1.0001 1.0000
(0.0213) (0.0279) (0.0002) (0.0005) (0.0002)
ISHMT99 0.5013*** 0.5178*** 0.9971*** 1.0003 0.9999
(0.0172) (0.0207) (0.0004) (0.0006) (0.0002)
ISHMT100 -0.0991*** -0.3130*** 1.0004*** 0.9979*** 1.0008***
(0.0248) (0.0326) (0.0001) (0.0004) (0.0002)
ISHMT101 0.3494*** 0.4439*** 0.9992*** 1.0010** 0.9998**
(0.0244) (0.0286) (0.0002) (0.0004) (0.0001)
ISHMT102 0.2388*** 0.2444*** 0.9994*** 1.0001 1.0000
(0.0233) (0.0269) (0.0001) (0.0004) (0.0001)
ISHMT103 0.6276*** 0.7591*** 0.9998* 1.0001 1.0000
(0.0781) (0.0978) (0.0001) (0.0001) (0.0000)
ISHMT104 0.5272** 0.7554** 1.0000 1.0000 1.0000
(0.2147) (0.3379) (0.0000) (0.0000) (0.0000)
ISHMT105 0.7845 1.0752** 1.0000 1.0000 1.0000
(0.6069) (0.4777) (0.0000) (0.0000) (0.0000)
ISHMT106 0.4656*** 0.4309*** 1.0000 1.0000 1.0000
(0.1298) (0.1303) (0.0000) (0.0001) (0.0000)
ISHMT107 0.2399* 0.4130*** 1.0001 1.0001 1.0000
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
(0.1242) (0.1011) (0.0000) (0.0001) (0.0000)
ISHMT108 0.7920*** 0.8287*** 1.0000 1.0000 1.0000
(0.1156) (0.1150) (0.0001) (0.0001) (0.0000)
ISHMT109 0.5508*** 0.2835*** 1.0006*** 0.9990*** 0.9997***
(0.0394) (0.0366) (0.0002) (0.0002) (0.0001)
ISHMT110 0.7767*** 0.6737*** 0.9998 0.9989*** 1.0000
(0.0241) (0.0256) (0.0004) (0.0004) (0.0001)
ISHMT111 0.0561*** -0.0727*** 0.9998*** 0.9955*** 1.0005***
(0.0139) (0.0152) (0.0001) (0.0007) (0.0001)
ISHMT112 0.1732*** 0.1397*** 1.0001 0.9988* 1.0000
(0.0137) (0.0141) (0.0002) (00007x) (0.0000)
ISHMT113 -0.5909** -0.3513 1.0000 1.0000 1.0000
(0.2718) (0.4787) (0.0000) (0.0000) (0.0000)
ISHMT114 0.1311*** 0.0647*** 1.0010*** 0.9925*** 0.9995***
(0.0085) (0.0085) (0.0002) (0.0013) (0.0001)
ISHMT115 0.5084*** 0.5502*** 1.0003** 1.0001 1.0000
(0.0537) (0.0484) (0.0001) (0.0001) (0.0000)
ISHMT116 0.1957*** 0.1506*** 0.9998 0.9991* 1.0000
(0.0177) (0.0187) (0.0001) (0.0005) (0.0000)
ISHMT117 0.7646*** 0.9425*** 0.9996 1.0013*** 0.9999
(0.0279) (0.0302) (0.0003) (0.0003) (0.0001)
ISHMT118 1.1389*** 1.0693*** 1.0001 0.9993* 1.0000
(0.0249) (0.0257) (0.0006) (0.0004) (0.0000)
ISHMT119 1.2447*** 1.0873*** 0.9992 0.9990*** 1.0001
(0.0302) (0.0331) (0.0005) (0.0003) (0.0001)
ISHMT120 0.5973*** 0.5402*** 1.0010* 0.9981*** 0.9999
(0.0142) (0.0143) (0.0006) (0.0007) (0.0001)
ISHMT121 0.8667*** 0.7511*** 1.0002 0.9999 1.0000
(0.0705) (0.0660) (0.0002) (0.0001) (0.0000)
ISHMT122 -0.1403*** 0.0378* 0.9999 1.0025*** 1.0001
(0.0212) (0.0215) (0.0001) (0.0004) (0.0001)
ISHMT123 0.6030*** 0.6182*** 1.0015*** 1.0003 1.0000
(0.0186) (0.0181) (0.0004) (0.0005) (0.0001)
ISHMT124 1.3337** (omitted) 1.0000 1.0000 1.0000
(0.0069) (0.0000) (0.0000) (0.0000)
ISHMT125 0.1600*** 0.1536*** 0.9999 1.0000 1.0000
(0.0368) (0.0409) (0.0001) (0.0002) (0.0000)
ISHMT126 0.0790** -0.2029*** 1.0001 0.9985*** 0.9998**
(0.0326) (0.0315) (0.0000) (0.0003) (0.0001)
Table continues in following page.
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Table B.1: (continued)
Decomposition (as ratio)
2007/08 2014/15 Characteristics Coefficients Interaction
ISHMT127 0.0884** 0.2066*** 0.9998** 1.0006* 0.9997*
(0.0349) (0.0538) (0.0001) (0.0003) (0.0002)
ISHMT128 (omitted)
ISHMT129 0.3872 -2.8191*** 1.0000 0.9999 1.0001
(0.3508) (0.6755) (0.0000) (0.0001) (0.0001)
ISHMT130 0.1965*** 0.1311*** 0.9992*** 0.9969*** 1.0003***
(0.0115) (0.0125) (0.0002) (0.0008) (0.0001)
First Diagnosis - total effect 1.0161*** 0.9087*** 0.9912***
(0.0027) (0.0080) (0.0019)
Comorbidities 0.0734*** 0.0811*** 1.0517*** 1.0093*** 1.0053***
(0.0022) (0.0020) (0.0017) (0.0035) (0.0020)
Type of Provider
Large Provider Reference Category 1.0016*** 0.9963 1.0005
(0.0005) (0.0043) (0.0006)
Medium Provider -0.0050 0.0098 1.0008*** 1.0013 0.9999
(0.0060) (0.0065) (0.0002) (0.0034) (0.0003)
Small Provider -0.0042 -0.0147 1.0004*** 0.9977 1.0002
(0.0081) (0.0090) (0.0001) (0.0015) (0.0001)
Specialist Provider 0.1803*** 0.1666*** 1.0000 0.9993 1.0000
(0.0150) (0.0158) (0.0001) (0.0006) (0.0000)
Teaching Provider 0.0719*** 0.0731*** 1.0022*** 0.9980 0.9995
(0.0064) (0.0064) (0.0006) (0.0027) (0.0007)
Other Provider -0.0305 0.0390** 0.9988 1.0001 1.0011
(0.0575) (0.0191) (0.0009) (0.0001) (0.0009)
Type of Provider - total effect 1.0038*** 0.9928 1.0011
(0.0011) (0.0104) (0.0012)
Constant 6.5440*** 6.6594*** - 1.0523*** -
(0.0126) (0.0133) (0.0136)
Adjusted R-squared 0.6630 0.6666
N 66,079 75,343 141,422
Standard errors in parenthesis. ***, **, * represent 1%, 5% and 10% significance, respectively.
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B.2. Counterfactual Decomposition
Table B.2: Counterfactual Decomposition of Differences in Distributions - Log(Hospital Costs)
between 2007/08 and 2014/15 - 130 diagnosis groups
Quantile Differences between
the observable
distributions
Effects of
characteristics
Effects of coefficients
0.1 -0.109 -0.018 -0.091
[-0.188, -0.100] [-0.026, -0.011] [-0.100, -0.082]
0.2 -0.032 -0.014 -0.018
[-0.043, -0.021] [-0.021, -0.007] [-0.027, -0.009]
0.3 0.019 0.002 0.017
[0.007, 0.030] [-0.005, 0.008] [0.009, 0.025]
0.4 0.050 0.008 0.042
[0.037, 0.063] [0.001, 0.015] [0.033, 0.051]
0.5 0.081 0.016 0.065
[0.067, 0.095] [0.009, 0.023] [0.055, 0.074]
0.6 0.096 0.027 0.069
[0.082, 0.111] [0.019, 0.035] [0.060, 0.078]
0.7 0.110 0.044 0.066
[0.094, 0.126] [0.033, 0.054] [0.056, 0.076]
0.8 0.138 0.081 0.057
[0.118, 0.158] [0.068, 0.094] [0.043, 0.072]
0.9 0.216 0.184 0.032
[0.195, 0.238] [0.162, 0.207] [0.012, 0.051]
N 2007/08 66,079
N 2014/15 75,343
Pointwise Confidence Interval in parenthesis.
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Figure B.1: Counterfactual Decomposition of Differences in Distributions - Log(Hospital Costs)
between 2007/08 and 2014/15 - 130 diagnosis groups
